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ABSTRACT 
 
Sex Differences and the Effects of Exercise Training on Functional Vasodilation Following 
Arterial Occlusion in the BALB/c Mouse Spinotrapezius 
 
Britta Caroline Nelson 
 
 
Peripheral arterial occlusive disease (PAOD) often presents as intermittent claudication, which 
may be caused by impaired vasodilation. Impairment of resistance vessels may contribute to 
the pathogenesis of PAOD, and explain the poor correlation between resting blood flow and 
limb function. Collateral function following arterial occlusion is not well defined, however 
collaterals and arterialized collateral capillaries (ACCs) in male and female animal models 
exhibit impaired vasodilation following arterial occlusion, which can potentially be improved 
with exercise training. Furthermore, resistance vessels in the ischemic tree and stem are likely 
involved in the pathogenesis of PAOD, however the relative importance of each is unknown. 
Therefore, we measured functional vasodilation in pre-existing collaterals, ACCs, the ischemic 
tree, and the stem region, 7 and 21-days following spinotrapezius feed artery ligation in male 
and female BALB/c mice, and with exercise therapy. Vasodilation in ACCs was more impaired in 
female mice than in males. Generally, vasodilation was impaired at day-7, likely due to impaired 
endothelium-dependent and smooth muscle-dependent vasodilation in maturing collaterals, 
and recovered by day-21. Exercise training appears to enhance collateral reactivity, more in 
ACCs in males than in females, suggesting that its therapeutic benefits are linked not only to 
structural adaptation but also to vessel functionality. Therefore, future research is required to 
determine the cause of sex differences in exercise therapy to treat peripheral arterial occlusive 
disease. 
 
 
 
 
 
 
 
Keywords: collateral circulation, ischemia, exercise training, vasodilation, spinotrapezius, sex 
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Introduction 
Peripheral arterial occlusive disease (PAOD) most commonly presents as intermittent 
claudication, or ischemic pain during exercise [1,2]. Intermittent claudication is thought to be 
due to a mismatch between oxygen demand and supply that results from reduced perfusion 
pressure due to atherosclerotic plaque(s) that obstructs the arteries supplying the lower 
extremities [1]. However, the ankle-brachial index (ABI) (a diagnostic test for PAOD that 
compares arterial pressure in the arm and the ankle, and a measure of perfusion pressure) is 
not associated with pain-free walking distance [3,4,5], and over half of patients with PAOD have 
no symptoms at all [2]. Furthermore, an increase in resting calf blood flow has only a slight 
association with pain-free walking distance or time, suggesting that the pathophysiology of 
intermittent claudication is more complex than insufficient resting blood flow [5]. Impairment 
of resistance vessels, which dilate in response to exercise to allow a greater volume of blood 
flow to meet the increased metabolic demand, may contribute to the pathogenesis of PAOD, 
and explain the poor correlation between resting blood flow and limb function. Vasodilation is 
impaired in the upper [6] and lower [7] extremities in patients with PAOD, which appears to 
limit the effectiveness of the collateral circulation when metabolic demand is increased 
[8,9,10]. This suggests that impaired vasodilation of collateral vessels may be involved in the 
pathophysiology of PAOD, and may contribute to intermittent claudication [5]. Vasodilation is 
also impaired in immature collaterals in animal models [11], but restored after maturation 
[11,12,13]. At day-7 following spinotrapezius feed artery ligation, pre-existing collaterals (PECs, 
large arterioles that anastomose (i.e. connect) two different first or second-order arterioles and 
enlarge to serve as a natural bypass for blood flow following an arterial occlusion) have 
impaired endothelial-independent and endothelial-dependent dilation, and no impairment at 
day-21 [12]. Because the impairment is temporary, it is likely due to the immaturity of vascular 
smooth muscle cells (SMCs) during the outward remodeling phase because the cells need time 
to arrange and mature into contractile SMCs, which likely impairs their ability to effectively 
relax and contract [12]. Estrogen also has an effect on SMC functionality, however sex 
differences in collateral functional vasodilation following arterial occlusion are unknown [14]. 
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Therefore, studying collateral functional vasodilation following arterial occlusion will allow us to 
interrogate the impact of arteriogenesis on functional hyperemia [12].  
Even if their vasodilation is impaired, collaterals function as an important bypass following 
arterial occlusion to maintain tissue viability [2,9]. However, some patients with cardiovascular 
disease never develop collaterals, and only 33% of patients have angiographic evidence of 
coronary collaterals at the onset of acute myocardial infarction [14,15]. In mice with fewer or 
absent collaterals, bypass collateral connections form in response to arterial occlusion via 
collateral capillary arteriogenesis (CCA) to normalize shear stress across the collateral capillary 
bed [11,16]. Arterialized collateral capillaries (ACCs) reperfuse the downstream ischemic tissue 
in 2-7 days following feed artery ligation, and represent a possible therapeutic target for 
patients with PAOD who never develop arteriolar collaterals [17]. First, it is necessary to 
identify when vasodilation is restored in ACCs at to determine when ACCs are capable of 
maintaining normal tissue function. Seven-days following spinotrapezius feed artery ligation, 
vasodilation in ACCs is impaired, probably due to vascular smooth muscle cell dysfunction 
[12,16]. By day-21, ACCs regain the capacity to dilate in response to muscle contraction, and 
utilize similar vasodilation pathways as control vessels [12]. Even if ACCs may be a possible 
therapeutic target for patients with PAOD, sex differences in vasodilation capabilities of ACCs 
may exist. The pathophysiology of PAOD is dependent on sex, and women have worse 
prognosis than men, so it is likely that sex differences in ACC behavior exist. However, sex 
differences in vasodilation capabilities in ACCs have not been studied [4,23]. 
 
Although the collateral circulation is necessary to perfuse tissue downstream of a vascular 
occlusion and maintain viability [20], it is not sufficient to maintain normal tissue function [21]. 
For example, Rac2-/- and Nox2-/- mice have impaired hind paw perfusion following femoral 
artery ligation, yet surprisingly, no impairment in collateral enlargement [21]. This suggests that 
vascular resistance in the ischemic microcirculation is a major contributor to perfusion of the 
ischemic tree (the vascular tree directly downstream of the occlusion site) [21]. Similarly, 
despite improvements in muscle blood flow and perfusion pressure, endothelial-dependent 
vasodilation is impaired in the microcirculation of ischemic muscles in rat skeletal muscles 
 3 
[19,20]. Despite the benefits of collaterals, a reduced vasodilation in the ischemic zone is 
problematic following arterial occlusion. Clearly both collateral vasodilation and ischemic tree 
vasodilation could be involved in the pathogenesis of PAOD, but the relative importance of 
each is unclear. Characterizing both collateral and ischemic tree reactivity in the same 
preparation would allow for future work evaluating the relative contribution of each to tissue 
blood flow and function following arterial occlusion. 
 
In addition to differences in collateral formation, the pathophysiology of PAOD is also 
dependent on sex [24]. There is a similar prevalence of PAOD among men and women, but 
women with PAOD have a worse health status and a greater near-term mortality rate 
compared with men [4,23]. For example, there is a higher prevalence of critical limb ischemia, 
the most severe form of PAOD, among women [24,25]. Also, if the diagnosis of PAOD is based 
on ABI value alone, more women have PAOD than men, and women are more likely to have 
asymptomatic PAOD than men, potentially going undiagnosed [25]. In animal models, females 
have less blood flow recovery, and a higher vascular resistance in the hindlimb following arterial 
ligation, which could be a result of impaired revascularization or decreased vasodilation [27]. In 
general, there is a lack of scientific studies on collaterals in female mice, and studying 
vasodilation in collateral vessels of female animal models may explain the sexual dimorphism in 
PAOD [27]. 
 
Although the pathogenesis of PAOD is unclear, there is abundant evidence that exercise 
therapy is one of the best treatment strategies [28]. Therefore, to ease symptom severity and 
help patients with PAOD resume a normal lifestyle, exercise therapy, typically administered as a 
single oral recommendation without any supervision or follow up, is included in the guidelines 
for management of PAOD, but patient adherence is poor [2,27]. Specifically, up to a third of 
patients do not follow the recommended intensity, frequency, or duration of supervised 
training programs, limiting their effectiveness [2]. Compounding the adherence problem is the 
fact that the benefits of exercise therapy are probably due to multiple, poorly-understood 
mechanisms, including reducing arterial obstruction, reducing endothelial dysfunction, and 
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shortening the time to onset of inflammatory activation [5]. Clinical attempts have been made 
to enhance arteriogenesis, such as the delivery of growth factors such as VEGF and FGF that 
increase collateral blood flow following occlusion [29], and cell transplantation to the ischemic 
zone to produce the growth factors necessary for collateral enlargement [30]. While these 
clinical attempts increase collateral blood flow both pre- and post-occlusion, it is unclear 
whether this is due to enhanced arteriogenesis or improved vasodilation [2,28]. Regardless of 
the mechanism of action in collaterals, arteriolar reactivity is restored in ischemic muscles after 
mild, intermittent stimulation [32]. Furthermore, long-term supervised exercise training 
increases pain-free walking distance without increasing ABI or number of arteries, suggesting 
that the reduction of intermittent claudication is not a result of improved collateralization [33]. 
Because vasodilation is transiently impaired during arteriogenesis [17] and impaired 
vasodilation may contribute to intermittent claudication, improving vasodilation may be a more 
sensible treatment for PAOD than enhancing arteriogenesis. The benefits of exercise therapy in 
improving intermittent claudication symptoms in male patients with PAOD are well-defined, 
but there is a lack of data concerning female patients, as females represent a small portion of 
participants in existing exercise rehabilitation studies for PAOD [34]. However, based on these 
studies, women are less responsive to exercise training than men, and have a lower absolute 
claudication distance (walking distance until pain threshold is reached) following exercise 
therapy than men [2,34]. However, exercise generally improves claudication symptoms in both 
sexes, as absolute claudication distance increased by 264% in men and 209% in women 
following 12-months of exercise therapy [35]. Further comparison is necessary to determine sex 
differences in vasodilation following ischemia and exercise training, to determine if sex 
differences in IC and response to exercise therapy might be explained by differences in 
vasodilation. Since exercise is a known effective treatment for PAOD, inducing functional 
vasodilation will allow us to interrogate vasodilation in multiple vessel types within a single 
preparation following exercise treatment to determine the therapeutic effects of exercise 
training along the vascular tree [2,27]. If exercise therapy improves functional vasodilation in 
animal models, then the mechanism of exercise therapy may include improved vasodilation.  
Therefore, we tested the hypothesis that following arterial occlusion male BALB/c mice have 
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impaired vasodilation, and female BALB/c mice have a greater impairment in vasodilation, by 
measuring functional vasodilation in ACCs, PECs, the ischemic tree, and the stem region, 7 and 
21-days following spinotrapezius feed artery ligation. Additionally, we introduced voluntary 
exercise to test the hypothesis that exercise accelerates the recovery of functional vasodilation 
in male and female BALB/c mice at day-7. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 6 
Methods 
Animal Husbandry  
 
All procedures were performed according to protocols approved by the Institutional Animal 
Care and Use Committee (IACUC) of California Polytechnic State University. Male (n = 28) and 
female (n = 24) BALB/c mice (The Jackson Labs), aged 7-9 weeks, and weighing 26 ± 0.4g and 20 
± 0.3g, respectively, were used for these studies. Mice were housed in micro-isolator cages 
within a temperature-controlled room (20-23 C) in the University Vivarium. The room was 
inspected daily and maintained on 12-hour light/dark cycles. Males and females were 
segregated by sex, and each cage housed a maximum of four mice and was provided with 
rodent feed, water, and enrichment (bedding, a plastic ‘mouse house’, and a plastic tube). Mice 
receiving voluntary exercise therapy were provided with a mouse running wheel with a Hall-
effect sensor to record wheel revolutions (Model # 0297-0521,0501, Columbus Instruments).  
 
Spinotrapezius Ligation 
 
Mice were anesthetized in an induction chamber with 5% vaporized isoflurane in oxygen 
flowing at 0.8-1.2 l∙min-1, weighed, and transferred to a preparatory bench where anesthesia 
was maintained with 2-3% isoflurane at a flow rate of 0.8-1.2 1min-1. Prior to skin disinfection, 
trimming clippers and depilatory cream were used to remove the hair bilaterally on the dorsal 
aspect of the mouse on the spinotrapezius muscle. Mice were then transferred to a heating pad 
on the surgical stage, where core body temperature was maintained at 35 C with rectal-
thermistor feedback (Model TC-1000 Temperature Controller, CWE Inc.). An initial incision was 
made above the lateral, cranial edge of the left or right spinotrapezius muscle (alternating 
order), and the superficial connective tissue was blunt dissected. The dorsal fat pad was blunt 
dissected from the spinotrapezius muscle, and the lateral feed artery was identified on the 
lateral edge of the spinotrapezius muscle. The artery was separated from its paired vein and 
ligated with two individual strands from 6-0 silk suture; the feed artery was transected between 
the ligations. The skin incision was closed with 7-0 polypropylene suture. A sham surgery was 
performed on the contralateral muscle involved blunt dissecting the fat pad from the 
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spinotrapezius and locating the artery and vein pair, but not separating or ligating the feed 
artery.  
 
Voluntary Exercise 
 
Mice in the exercise therapy group were placed in cages containing four mice following 
spinotrapezius ligation. Each cage received a mouse exercise wheel with a magnetic indicator 
and a Hall-effect sensor that output to software to record wheel revolutions (Model number 
0297-0050,0051, Columbus Instruments). Wheel revolutions were recorded hourly and grouped 
by 12-hour light/dark cycles. Wheel revolutions were then converted to running distance in 
kilometers, using the following equation: 
 
𝑅𝑢𝑛𝑛𝑖𝑛𝑔 𝑑𝑖𝑠𝑡𝑎𝑛𝑐𝑒 =  # 𝑜𝑓 𝑟𝑒𝑣𝑜𝑙𝑡𝑢𝑖𝑜𝑛𝑠 ∗ 𝑤ℎ𝑒𝑒𝑙 𝑐𝑖𝑟𝑐𝑢𝑚𝑓𝑒𝑟𝑒𝑛𝑐𝑒 (𝑘𝑚) 
 
Functional Vasodilation 
 
The left or right spinotrapezius (alternating order) was exposed by an initial skin incision at the 
caudal end of the muscle, followed by removal of the skin, then removal of superficial fascia 
and connective tissue via blunt dissection; the contralateral side was then exposed. Following 
exposure, the entire muscle was covered with plastic wrap, and the mouse was moved into a 
supine position. Following a skin incision on the ventral neck, 100 µl of FITC-conjugated dextran 
(12.5mg/mL, 250,000 MW, 490 nm excitation, 520 nm emission, Sigma Aldrich) was injected in 
the jugular vein for contrast. The mouse was returned to the prone position, and two tungsten 
microelectrodes were placed lateral to the spine at the caudal end of the spinotrapezius muscle 
to induce contraction by electrical field stimulation. Proper placement of the electrodes was 
determined with a brief set of 2mA square waves of 200 µs duration at 1 Hz (LabChart and a 
PowerLab Data Acquisition System, ADInstruments). Following a 30-minute equilibration 
period, vessels were imaged using an intravital microscope (Olympus BXFM) and a Retiga 2000R 
mono camera (QImaging). Images were captured (QCapture Pro Image and Analysis) from the 
intravital fluorescence microscope with 5x and 10x objectives. The muscle was stimulated for 
90 seconds with a set of 2mA square waves of 200s duration at 8 Hz, and a second set of 
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images were captured immediately following stimulation. The same procedure was repeated 
for the contralateral muscle. After vasodilation measurements, mice were euthanized by 
cervical dislocation while anesthetized. 
 
Data Analysis 
 
Vessel diameters before and after muscle stimulation were measured using Image/J and the 
percent change was calculated. To minimize user error in Image/J measurements, each 
diameter was measured three times in Image/J and averaged, and the average value was 
recorded. Nine females and 13 male Balb/C mice used in this study had preexisting collaterals; 
all of these females and 9 males also developed ACCs. PECs exhibited similar dilations when 
ACCs were or were not present; ACCs exhibited similar dilatory behavior when PECs were or 
were not present. Therefore, ACC and PEC diameters from mice with both vascular structures 
(i.e. PECs and ACCs, n = 18) or only 1 (i.e. PECs, n = 4 or ACCs, n = 28) were analyzed irrespective 
of mouse anatomical variability. Differences between resting and dilated diameters were 
assessed using paired t-tests. Percent changes in diameter were calculated as the difference 
between the dilated and resting diameters divided by the resting diameter and multiplied by 
100%. Differences in means of ACCs, PECs, ischemic tree, and stem tree measurements based 
on time point (i.e. day-7 or day 21), sex, vessel order, ligation status (i.e. operated or sham-
operated), and vessel status (i.e. resting or dilated), were determined by ANOVA, Welch, and 
Wilcoxon tests. ANOVA tests were used for normal data with equal variances, utilizing Shapiro 
Wilk normality tests and F-tests for equal variances. Welch tests were used for normal data 
with unequal variances, and Wilcoxon tests with Levene’s tests for equal variances were used 
for data that violated the normality test. Data are expressed as mean ± standard error. 
 
 
 
 
 
 9 
Results 
To better understand the effects of arterial obstruction on vasodilation in male and female 
mice, we evaluated functional vasodilation following spinotrapezius feed artery ligation. The 
spinotrapezius muscle allows for visualization of pre-existing collaterals (PECs), arterialized 
collateral capillaries (ACCs), the ischemic zone, and the stem region, all in the same tissue 
preparation.  
 
Functional Vasodilation in Pre-existing Collaterals 
 
Pre-existing collaterals (PECs), large arterioles that anastomose (i.e. connect) two different first 
or second-order arterioles and enlarge to serve as a natural bypass for blood flow following an 
arterial occlusion, are widely studied [11,35,36,37], and help to preserve downstream tissue 
viability following arterial occlusion (Figure 1) [20]. PECs occur less frequently in BALB/c mice in 
the hindlimb [11], spinotrapezius [17], and cerebral vasculature [39] than in other strains, and 
exhibit a delayed impairment in enlargement, with comparable enlargement to C57Bl/6 mice at 
day-7 and reduced enlargement at day-21 [11,15]. PECs in the spinotrapezius of male BALB/c 
mice have impaired endothelial-independent and endothelial-dependent dilation at day-7 [12]. 
Further, vasodilation capabilities are not completely restored at day-21, possibly due to a 
variation in smooth-muscle cell phenotype [12], while the vasodilation capabilities of PECs in 
female BALB/c mice remains unknown. 
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Figure 1. Representative Photomontage of Remodeled Vasculature with Pre-existing 
Collaterals in BALB/c Spinotrapezius Following Feed Artery Ligation. Boxed areas of interest 
include A) the re-entry vascular tree (ischemic zone), B) the midzone (arrow illustrates a PEC in 
the field of view) and C) the stem vascular tree. Blood flow moves from stem (C) to re-entry (A) 
following arterial occlusion. 
 
PECs appeared in 9 of 24 females and 13 of 24 males (Figures 2AB, 3AB). Arterioles with similar 
dilated diameters in contralateral sham-operated muscles were used for comparisons. PECs 
consist of three zones: the stem (the site at which blood flow from another tree is entering the 
collateral bypass), the midzone (the region near the middle of the collateral bypass), and the re-
entry (the site at which blood flow re-enters the ischemic tree) [40]. Following occlusion, blood 
flow and shear stress increase across the regions of the PEC, such that the stem increases from 
high to very high flow rates, the midzone increases from oscillatory flow to very high flow rates, 
and the reentry increases from high to very high flow rates in the opposite direction. Because 
arteriogenesis is induced by increases in shear stress, the differences between final and initial 
conditions at each collateral zone causes different amounts of remodeling in each zone [40,41]. 
Since remodeling likely impacts vasodilation, we evaluated vasodilation in each collateral zone.   
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By day-7 following femoral artery ligation, PEC remodeling is largely complete in the C57BL/6 
strain, and max diameters do not appear to increase further [34,38]. We studied vasodilation in 
the different zones of PECs to test the hypothesis that by day-7 following feed artery ligation 
PECs are fully enlarged but not mature, and that vasodilation is more impaired in the midzone 
than in the stem and re-entry, since relative remodeling of the stem and re-entry are less. 
Reduction in vasodilation in the PEC stem were only signification in female mice, compared to 
control, 27  1.7 m to 40  4.4 m and 17  2.7 m to 34  4.8 m, respectively; the male PEC 
stem dilated from 34  5.9 m to 56  6.8 m, similar to 21  3.1 m to 41  5 m in control 
arterioles (Figure 2). Similar to the stem, PECs in the re-entry region in males and females were 
of similar resting diameter and dilated to a similar extent, 39  4 m to 60  2.2 m and 39  10 
m to 60  14.7 m, respectively (Figure 2). Although there was no difference between male 
and female re-entry PECs, they dilated less than control arterioles from males and females, 24  
4.6 m to 61  5.4 m and 26  3.4 m to 50  5.9 m, respectively (Figure 2). Unlike the stem 
and reentry, PECs in the midzone dilated less in males and females as compared to control, 
which dilated from 36  3.6 m to 51  3.4 m and 28  2.4 m to 41  6.5 m, respectively, 
compared to 23  2.0 m to 47  4.1 m and 23  3.3 m to 44  5.4 m, respectively, in 
control arterioles (Figure 2).  
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Figure 2. Functional Vasodilation in BALB/c Spinotrapezius Pre-existing Collaterals at Day-7. 
Representative images before (A) and after (B) 90 seconds of muscle contraction as visualized 
by intravital microscopy. Red arrow indicates a PEC in the field of view. Diameters (m) at rest 
and following muscle contraction (dilated) seven days following spinotrapezius feed artery 
ligation in the C) re-entry, D) midzone, and E) stem regions. F) Diameter increases from C, D, 
and E expressed as a percent change p<.05 vs. resting *, vs. sham &, vs. re-entry %, vs. midzone 
@ (n=5 males, n=4 females). 
 
 
A B 
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At day-21, after the presumptive maturation period, resting and dilated PEC measurements 
generally more closely resembled those of contralateral sham operated-muscles than at day-7 
(Figure 3). Although general trends were more similar to the control, resting diameters of re-
entry PECs in operated males were larger than midzone and stem arterioles, and percent 
change in diameter was greater in males than females in re-entry and midzone PECs, but 
females had a greater percent change in diameter in stem region PECs (Figure 3). Specifically, 
PECs in the `stem region in males and females dilated from 21  3.7 m to 58  5.1 m and 18  
4.1 m to 48  12.5 m, respectively, compared to 22  3.2 m to 43  5.5 m and 17  1.7 m 
to 40  4 m, respectively, in control arterioles (Figure 3). Pre-existing collaterals in the re-entry 
region in males and females dilated from 30  2.8 m to 59  5.7 m and 27  5.7 m to 50  
11 m, respectively, compared to 31  2.9 m to 58  5.3 m and 29  2.1 m to 65  4.2 m, 
respectively, in control arterioles (Figure 3). Pre-existing collaterals in the midzone in males and 
females dilated from 23  5.4 m to 49  8.6 m and 19  3.1 m to 41  9.8 m, respectively, 
compared to 28  2.4 m to 53  3.9 m and 23  2.9 m to 51  5.7 m, respectively, in 
control arterioles (Figure 3).  
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Figure 3. Functional Vasodilation in BALB/c Spinotrapezius Pre-existing Collaterals at Day-21. 
Representative images before (A) and after (B) 90 seconds of muscle contraction as visualized 
by intravital microscopy. Red arrow indicates a PEC in the field of view. Diameters (m) at rest 
and following muscle contraction (dilated) twenty-one days following spinotrapezius feed 
artery ligation in the C) re-entry, D) midzone, and E) stem regions. F) Diameter increases from 
C, D, and E expressed as a percent change p<.05 vs. resting *, vs. sham &, vs. day-7 $, vs. re-
entry %, vs. midzone @, vs. stem ! (n=6 males, n=3 females). 
A B 
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Functional Vasodilation in ACCs 
 
Because exercise training was only performed with a subset of mice, there was an insufficient 
number of PECs in exercise-trained mice to include in analysis. 
 
Although PECs can help maintain tissue viability following arterial occlusion [2,9], some patients 
never develop collaterals, a condition that is mimicked in laboratory mice, such as the BALB/C 
strain [14,16]. Therefore, we studied functional vasodilation in ACCs to determine how 
collateral capillary arterialization (CCA) affects vasodilation in arterialized capillaries in males 
and females when enlargement is expected to be complete (day-7), when ACCs are expected to 
be largely mature (day-21), and following exercise therapy at day-7, to test the hypotheses that 
female BALB/c mice have a greater impairment in functional vasodilation in ACCs than male 
BALB/c mice, and that female mice are less responsive to exercise therapy [34]. 
 
Arterialized collateral capillaries reliably form in BALB/c mice, and have negligible reactivity in 
males seven days following feed artery ligation, while the reactivity of ACCs in female BALB/c 
mice is unknown. Before evaluating functional vasodilation, intravital-assessed morphology 
confirmed the presence of ACCs, i.e. tortuous and enlarged capillaries connecting two terminal 
arterioles from adjacent arteriolar trees [17]. Arterialized capillaries appeared in 24 of 24 
females and 24 of 28 males at day-7 or day-21 following spinotrapezius artery ligation (Figure 
4); contralateral sham muscles exhibited no sign of CCA (not shown).  
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Figure 4. Representative Photomontage of Remodeled Vasculature in BALB/c Spinotrapezius 
Following Feed Artery Ligation. Representative image of a female BALB/c spinotrapezius 21-
days following feed artery ligation. Boxed areas of interest include A) the re-entry vascular tree 
(ischemic zone), B) the midzone with ACCs, and C) the stem vascular tree. D) Arrow illustrates 
an ACC in the field of view. 
 
At day-7, ACCs in males were larger than in females, and exhibited greater vasodilation, 7.9  
0.4 m to 8.7  0.6 m and 6.1  0.2 m to 6.4  0.3 m, respectively (Figure 5). However, the 
vasodilation of male and female ACCs was markedly less than in sham-operated terminal 
arterioles of comparable resting diameter, which nearly doubled in size following muscle 
contraction in males and females, 7.4  0.3 m to 13.7  0.4 m and 5.8  0.3 m to 11  0.5 
m, respectively (Figure 5). Consistent with ACCs, diameters of terminal arterioles in sham-
operated females were smaller than in males.  
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Figure 5. Functional Vasodilation in BALB/c Spinotrapezius Arterialized Capillaries at Day-7. 
Representative images before (A) and after (B) 90 seconds of muscle contraction as visualized 
by intravital microscopy. Red arrow indicates an ACC in the field of view. C) Diameters (m) at 
rest and following muscle contraction (dilated) seven days following spinotrapezius feed artery 
ligation. D) Diameter increases from C expressed as a percent change p<0.05 vs. resting *, vs. 
sham &, and vs. males # (n=9 males, n=9 females). 
 
At day-21, after the presumptive maturation period, ACCs in males still had larger diameters 
than females. However, unlike day-7, there was no difference in vasodilation between sham 
and operated muscles, and resting diameters were smaller in day-21 ACCs (Figure 6). However, 
dilated diameters were greater for both males and females at day-21 as compared to day-7, 6.4 
 0.4 m to 11.9  0.7 m and 5.1  0.3 m to 10.2  0.7 m, respectively, compared to 6.9  
0.5 m to 12.4  0.8 m and 6.0  0.4 m to 11.3  0.8 m, respectively, in control (Figure 6). 
Interestingly, percent change in diameter was greater in operated females than operated males 
at day-21. 
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Figure 6. Functional Vasodilation in BALB/c Spinotrapezius Arterialized Capillaries at Day-21. 
Representative images before (A) and after (B) 90 seconds of muscle contraction as visualized 
by intravital microscopy. Red arrow indicates an ACC in the field of view. C) Diameters (m) at 
rest and following muscle contraction (dilated) twenty-one days following spinotrapezius feed 
artery ligation. D) Diameter increases from C expressed as a percent change p<0.05 vs. resting 
*, vs. males #, vs. day-7 $ (n=12 males, n=8 females). 
 
Although vasodilation was restored by day-21, if the natural history of ACC development is 
similar or longer in humans, the clinical relevance of this potential therapeutic target may be 
reduced because patient adherence and follow-up may be poor. It is possible that ACC 
development can be accelerated, by a mechanism such as exercise. Exercise is a widely-used 
effective therapy for patients with PAOD, but it’s mechanism of action is unclear [2]. Therefore, 
we introduced exercise therapy to determine if exercise could accelerate the restoration of 
vasodilation by day-7, and to determine if there is some support for improved collateral 
vasodilation, which could possibly explain some of the benefits of exercise. Voluntary exercise 
increased vasodilation capacity in ACCs for both males and females, 7.3  0.4 m to 9.4  0.5 
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m and 6.4  0.6 m to 7.6  0.7 m, respectively (Figure 7). Although vasodilation was greater 
than in the sedentary group, it was still less than in terminal arterioles of the sham-operated 
males and females, to 7.2  0.3 m to 14.3  0.7 m and 6.6  0.4 m to 12.2  0.7 m, 
respectively (Figure 7). Interestingly, a smaller percent change in diameter was seen in 
operated females than operated males.  
 
 
 
Figure 7. Functional Vasodilation in BALB/c Spinotrapezius Arterialized Capillaries at Day-7 
with Voluntary Exercise Therapy. Representative images before (A) and after (B) 90 seconds of 
muscle contraction as visualized by intravital microscopy. Red arrow indicates an ACC in the 
field of view. C) Diameters (m) at rest and following muscle contraction (dilated) seven days 
following spinotrapezius feed artery ligation with voluntary exercise therapy with running 
wheel. D) Diameter increases from C expressed as a percent change p<0.05 vs. resting *, vs. 
sham &, vs. males #, vs. day-7 $ (n=8 males, n=7 females). 
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Functional Vasodilation in the Ischemic Tree 
 
Although the collateral circulation is the primary site of blood flow resistance, the 
microcirculation in the ischemic zone has a major contribution to the overall resistance to blood 
flow in the ischemic tree. Understanding the natural history of vasodilation in the ischemic zone 
will help identify potential therapeutic targets for improving its function. Therefore, we tested 
the hypothesis that the ischemic tree has significantly impaired vasodilation at day-7, improved 
vasodilation at day-7 with exercise therapy, and restored vasodilation at day-21.  
 
PECs originating from ischemic arteriolar trees likely influence the vascular reactivity of the 
ischemic tree because they provide an alternate route for blood flow to reach the ischemic 
tree. To study the arteriolar tree arising from the ligated feed artery independent from any 
influence of PECs, measurements from vascular trees where PECs originated were not included 
in the analysis. All orders of arterioles in the ischemic tree in males and females dilated less 
than in the contralateral sham-operated muscles at day-7, and there were no differences 
between male and female dilation (Figure 8). First-order arterioles from the ischemic tree in 
males and females dilated from 48  4.4 m to 53  3.6 m and 46  14 m to 54  13 m, 
respectively, compared to 34  4.5 m to 61  5.3 m and 26  3.4 m to 50  5.9 m, 
respectively, in control arterioles (Figure 8). Second-order arterioles from the ischemic tree in 
males and females dilated from 40  2.1 m to 45  2.8 m and 32  3.8 m to 35  3.6 m, 
respectively, compared to 23  2.1 m to 47  4.1 m and 23  3.3 m to 44  5.4 m, 
respectively, in control arterioles (Figure 8). Third-order arterioles from the ischemic tree in 
males and females dilated from 24  7.6 m to 28  9.2 m and 24  1.4 m to 32  3.5 m, 
respectively, compared to 21  3.1 m to 41  5 m and 17  2.7 m to 34  4.8 m, 
respectively, in control arterioles (Figure 8).  
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Figure 8. Functional Vasodilation in BALB/c Spinotrapezius Arterioles from the Ischemic Tree 
at Day-7. Representative images before (A) and after (B) 90 seconds of muscle contraction as 
visualized by intravital microscopy. Red arrow indicates a second-order ischemic tree vessel in 
the field of view. Diameters (m) at rest and following muscle contraction (dilated) seven days 
following spinotrapezius feed artery ligation in C) first, D) second, and E) third-order vessels. F) 
Diameter increases from C, D, and E expressed as a percent change p<.05 vs. resting *, vs. sham 
& (n=9 males, n=9 females). 
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By day-21, vasodilation significantly improved in arterioles from the ischemic tree compared to 
day-7 (Figure 9). Percent change in diameter of first-order arterioles in operated males, first-
order arterioles in sham-operated females, and second and third-order arterioles in operated 
males and females were larger than at day-7. At day-21, first-order arterioles from the ischemic 
tree in males and females dilated from 39  4.7 m to 77  9.4 m and 30  4 m to 60  8.4 
m, respectively compared to 31  2.9 m to 58  5.3 m and 29  2.1 m to 65  4.2 m, 
respectively in control arterioles (Figure 9). Second-order arterioles from the ischemic tree in 
males and females dilated from 29  2.8 m to 60  2.1 m and 20  3.3 m to 43  5.5 m, 
respectively compared to 28  2.4 m to 53  3.9 m and 23  2.9 m to 51  5.7 m, 
respectively in control arterioles (Figure 9). Resting and dilated diameters in females were 
smaller than respective diameters in males. Third-order arterioles from the ischemic tree in 
males and females dilated from 23  2.5 m to 50  4.9 m and 20  3.8 m to 42  7.1 m, 
respectively compared to 22  3.2 m to 43  5.5 m and 17  1.7 m to 40  4 m, 
respectively in control arterioles (Figure 9).  
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Figure 9. Functional Vasodilation in BALB/c Spinotrapezius Arterioles from the Ischemic Tree 
at Day 21. Representative images before (A) and after (B) 90 seconds of muscle contraction as 
visualized by intravital microscopy. Red arrow indicates a second-order ischemic tree vessel in 
the field of view. Diameters (m) at rest and following muscle contraction (dilated) twenty-one 
days following spinotrapezius feed artery ligation in C) first, D) second, and E) third-order 
vessels. F) Diameter increases from C, D, and E expressed as a percent change p<.05 vs. resting 
*, vs. males #, vs. day-7 $ (n=12 males, n=8 females). 
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Exercise therapy only slightly increased functional vasodilation in ischemic tree arterioles. At 
day-7 with exercise therapy, first-order arterioles from the ischemic tree in males and females 
dilated from 60  3.5 m to 71  4.2 m and 51  2.1 m to 57  2 m, respectively, compared 
to 35  2.7 m to 63  4.2 m and 35  1.3 m to 57  2.7 m, respectively, in control 
arterioles (Figure 10). Additionally, first-order dilated arteriole diameters in operated males 
were almost 15 m larger than those in females. Exercise therapy increased vasodilation in 
second-order arterioles in males and females as compared to sedentary day-7, 42  1.8 m to 
47  1.6 m and 37  1.7 m to 44  1.3 m, respectively compared to 24  1.3 m to 49  2.1 
m and 21  2.1 m to 39  2.7 m, respectively, in control arterioles (Figure 10). Third-order 
arterioles were larger in dilated diameter in day-7 with exercise therapy in males than in 
sedentary day-7 males, however, they were smaller in diameter in day-7 with exercise therapy 
in females compared to sedentary day-7. Exercise therapy increased vasodilation in third-order 
arterioles in males and females as compared to sedentary animals, 26  2.5 m to 34  3.2 m 
and 29  1.4 m to 35  1.3 m, respectively, compared to 16  1.1 m to 32  2 m and 16  
1.1 m to 28  2.3 m, respectively, in control arterioles (Figure 10). 
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Figure 10. Functional Vasodilation in BALB/c Spinotrapezius Arterioles from the Ischemic Tree 
at Day-7 with Voluntary Exercise Therapy. Representative images before (A) and after (B) 90 
seconds of muscle contraction as visualized by intravital microscopy. Red arrow indicates a 
third-order ischemic tree vessel in the field of view. Diameters (m) at rest and following 
muscle contraction (dilated) seven days following spinotrapezius feed artery ligation with 
voluntary exercise therapy with running wheel in C) first, D) second, and E) third-order vessels. 
F) Diameter increases from C, D, and E expressed as a percent change p<.05 vs. resting *, vs. 
sham &, vs. males #, vs. day-7 sedentary $ (n=8 males, n=7 females). 
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Functional Vasodilation in the Stem Region 
 
Although collaterals are the primary site of resistance, flow in collaterals is dependent upon 
input from the stem region, because collaterals usually materialize from the second or third-
order of the stem tree. Following feed artery ligation, the significant increase in shear stress in 
the stem region leads to flow-induced vasodilation and subsequently outward remodeling [43]. 
We tested the hypothesis that the stem region exhibits impaired functional vasodilation at day-
7 in sedentary mice, which will be similar to sham-operated mice day-21, and partially 
recovered at day-7 with exercise therapy. Diameters in operated muscles were compared to 
first, second, and third-order arterioles in the re-entry tree in sham-operated muscles. Female 
stem arterioles had a larger percent change in diameter across all orders when compared to 
males. At day-7, first-order arterioles from the stem region in males and females dilated from 
49  16 m to 80  14 m and 42  4.6 m to 81  6.7 m, respectively, compared to 34  4.5 
m to 61  5.3 m and 26  3.4 m to 50  5.9 m, respectively, in control arterioles (Figure 
11). Second-order arterioles from the stem region in males and females dilated from 51  9.4 
m to 74  13.6 m and 27  3 m to 56  5.9 m, respectively, compared to 23  2.1 m to 47 
 4.1 m and 23  3.3 m to 44  5.4 m, respectively, in control arterioles (Figure 11). Third-
order arterioles from the stem region in males and females dilated from 33  5.3 m to 45  8.1 
m and 20  2.1 m to 44  4.9 m, respectively, compared to 21  3.1 m to 41  5 m and 
17  2.7 m to 34  4.8 m, respectively, in control arterioles (Figure 11).  
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Figure 11. Functional Vasodilation in BALB/c Spinotrapezius Arterioles from the Stem Region 
at Day-7. Representative images before (A) and after (B) 90 seconds of muscle contraction as 
visualized by intravital microscopy. Red arrow indicates a second-order stem region vessel in 
the field of view. Diameters (m) at rest and following muscle contraction (dilated) seven days 
following spinotrapezius feed artery ligation in C) first, D) second, and E) third-order vessels. F) 
Diameter increases from C, D, and E expressed as a percent change p<.05 vs. resting *, vs. sham 
&, vs. males # (n=9 males, n=9 females). 
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In general, resting and dilated diameters were smaller in first, second, and third-order arterioles 
from the stem region at day-21 compared to day-7 (Figure 12). Arterioles in operated muscles 
were compared to similar sized first, second, and third-order arterioles in sham-operated 
muscles. At day-21, dilated diameters in first-order arterioles in males were larger than at day-
7, and diameters in females were smaller, 40  46.9 m to 83  11.9 m and 35  0.1 m to 74 
 1.8 m, respectively compared to 31  2.9 m to 58  5.3 m and 29  2.1 m to 65  4.2 
m, respectively in control arterioles (Figure 12). Second-order arterioles in males and females 
had greater functional vasodilation than control arterioles. Second-order arterioles from the 
stem region in males and females dilated from 26  3.5 m to 62  7 m and 22  2 m to 57  
2 m, respectively compared to 28  2.4 m to 53  3.9 m and 23  2.9 m to 51  5.7 m, 
respectively in control arterioles (Figure 12).  Third-order arterioles from the stem region in 
males and females were not difference from control or each other, and dilated from 22  2.4 
m to 41  4.6 m and 18  2.1 m to 41  9.8 m, respectively compared to 22  3.2 m to 43 
 5.5 m and 17  1.7 m to 40  4 m, respectively in control arterioles (Figure 12). 
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Figure 12. Functional Vasodilation in BALB/c Spinotrapezius Arterioles from the Stem Region 
at Day-21. Representative images before (A) and after (B) 90 seconds of muscle contraction as 
visualized by intravital microscopy. Red arrow indicates a second-order stem region vessel in 
the field of view. Diameters (m) at rest and following muscle contraction (dilated) twenty-one 
days following spinotrapezius feed artery ligation in C) first, D) second, and E) third-order 
vessels. F) Diameter increases from C, D, and E expressed as a percent change p<.05 vs. resting 
*, vs. sham &, vs. day-7 $, (n=12 males, n=8 females). 
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Arterioles from the stem region in males and females at day-7 with exercise treatment closely 
resembled those of sedentary males and females at day-21 at all vascular tree diameter orders 
(Figure 13). Males and females with exercise therapy had similar first-order arteriole resting 
and dilated diameters to respective diameters in sedentary males and females at day-21. 
Arterioles in operated muscles were compared to similarly-sized first, second, and third-order 
arterioles in sham-operated muscles. Exercise increased dilated first-order arteriole diameters 
in males and females when compared to sedentary day-7, 45  3.4 m to 86  3.4 m and 45  
1.9 m to 88  2.6 m, respectively, compared to 35  2.7 m to 63  4.2 m and 35  1.3 m 
to 57  2.7 m, respectively, in control arterioles (Figure 13). Exercise reduced resting and 
dilated diameters in second-order arterioles in males, and increased vasodilation compared to 
sedentary day-7 males, so diameters appeared more like day-21 diameters. Also, exercise 
increased resting and dilated diameters in second-order arterioles in females compared to 
sedentary day-7 females, and did not affect percent change of diameters. Exercise decreased 
resting and dilated diameters in second-order arterioles in day-7 males, and did not change 
diameters in females, 32  2.3 m to 67  1.9 m and 35  2.6 m to 74  4.5 m, respectively, 
compared to 24  1.3 m to 49  2.1 m and 21  2.1 m to 39  2.7 m, respectively, in 
control arterioles (Figure 13). Exercise decreased resting diameters and did not change dilated 
diameters in third-order arterioles in male compared to sedentary day-7 males, although 
exercise enhanced vasodilation. Exercise did not change third-order arteriole diameters or 
percent change in diameter in females. Exercise slightly decreased resting diameters in third-
order arterioles in males compared to day-7, and did not change diameters in females, 24  1.3 
m to 46  2.6 m and 21  2.2 m to 49  4.4 m, respectively, compared to 16  1.1 m to 
32  2 m and 16  1.1 m to 28  2.3 m, respectively, in control arterioles (Figure 13). 
Exercise yielded a larger percent change in diameter females when compared to sham-
operated diameters (Figure 13). 
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Figure 13. Functional Vasodilation in BALB/c Spinotrapezius Arterioles from the Stem Region 
at Day-7 with Voluntary Exercise Therapy. Representative images before (A) and after (B) 90 
seconds of muscle contraction as visualized by intravital microscopy. Red arrow indicates a 
second-order stem region vessel in the field of view. Diameters (m) at rest and following 
muscle contraction (dilated) seven days following spinotrapezius feed artery ligation with 
voluntary exercise therapy with running wheel in C) first, D) second, and E) third-order vessels. 
F) Diameter increases from C, D, and E expressed as a percent change p<.05 vs. resting *, vs. 
sham &, vs.day-7 sedentary $ (n=8 males, n=7 females). 
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Exercise Therapy 
 
Because exercise therapy was voluntary and mice in each cage had access to a communal 
running wheel, we recorded distance run per cage to determine if distance run correlated with 
the amount of functional vasodilation at day-7, and how distance run correlates with vessel 
maturity with time (Figure 14). As distance run increased, average percent change in diameter 
generally increased (Figure 14). The two cages with male mice ran 84.8 km and 55.7 km, while 
the two cages with female mice ran 59.4 km and 70.4 km in the 7-day period (Figure 15). Mice 
ran more during daily 12-hour dark cycles (~5 km to 14 km per cycle) when compared to 12-
hour light cycles (~0.2 km to 2.5 km per cycle) (Figure 16). 
 
 
Figure 14. Distance Run vs. Percent Change in Diameter. Distance run per cage versus average 
percent change in diameter in first order stem arterioles at day-7 with exercise (n=16). 
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Figure 15. Estimated Total Running Distance per Mouse. Total running distance in kilometers 
estimated per mouse per cage and total running distance per cage of four mice over the seven-
day period following spinotrapezius feed artery ligation (n=16). 
 
 
 
Figure 16. Distance Run Over 12 Hour Light/Dark Cycles. Distance run in kilometers of each 
cage over seven-day period following spinotrapezius feed artery ligation. Distance 
measurements taken for each 12-hour light/dark cycle (7AM-7PM light, 7PM-7AM dark) (n=16). 
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Discussion  
Peripheral artery disease often presents as intermittent claudication, which may be caused by 
impaired vasodilation of collateral vessels. Collateral vessel functionality following arterial 
occlusion is not well defined [11,13,43] and there is a lack of studies in female collaterals [27], 
despite the fact that females with PAOD have a worse health status than males [4,23]. Even if 
their vasodilation is impaired, collaterals function as an important bypass following arterial 
occlusion to preserve downstream tissue integrity. However, some mice do not have 
collaterals, and are at greater risk for ischemic injury. These mice depend on arterialized 
collateral capillaries to reperfuse downstream tissue following feed artery ligation [17], which 
represents a possible therapeutic target for patients who never develop collaterals. The 
ischemic microcirculation also plays an important role in perfusion following occlusion because 
it is a major contribution to the overall resistance to blood flow in the ischemic tree [21]. 
Studying vasodilation in the ischemic microcirculation in relation to the collateral in a single 
preparation will provide insight into the relative importance of each of these resistance 
networks. Although collaterals are the primary site of resistance, flow in collaterals is 
dependent upon input from the stem region. Because collaterals usually materialize from the 
2nd or 3rd order of the stem tree, vasodilation responsiveness in the stem region could impact 
the potential utility of collaterals, necessitating an understanding of upstream vascular 
function. Finally, given that blood flow is reduced following occlusion, exercise therapy, a 
known effective treatment for PAOD, increases collateral blood flow [31], but it remains 
unknown if exercise improves blood flow by enhancing structural adaptations or vascular 
reactivity. Therefore, we assessed functional vasodilation in ACCs, PECs, the ischemic tree, and 
the stem region, in immature and mature vessels, and with and without exercise therapy.  
 
Almost half of mice (9 of 24 females and 13 of 24 males) had PECs at day-7 or day-21 following 
arterial ligation. The reason for the greater number of PECs in males is unknown, but in general, 
variation in the number of PECs is genetic [45]. Interestingly, all female mice had ACCs, while 
some males did not. This could be due to more robust remodeling in males, because PECs in 
males were able to remodel more robustly to become a sufficiently low resistance pathway that 
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shear stress did not appreciably increase in the ACC, while females may always form ACCs due 
to sufficiently high resistances in the PEC circulation. This hypothesis is supported by the 
observation that when mice did not have any PECs, they always developed ACCs. In general, 
diameters in females (average weight 20 ± 0.3g) were less than in males (average weight 26 ± 
0.4g), again, possibly because females have less robust remodeling than males [27]. 
 
At day-7, vasodilation was impaired in the re-entry, midzone, and stem regions of PECs, 
however, the magnitude of the impairment was far less than in ACCs. This is likley because 
SMCs surround PECs prior to arterial occlusion, and must proliferate and reorganize in response 
to occlusion, whereas SMCs must first be recruited in ACCs, potentially causing a variation in 
reactivity between the vessel types at day-7 [9,12]. Dilation was more impaired in the midzone 
than in the stem or re-entry regions of PECs, which was expected because relative remodeling is 
the greatest in the midzone. Additionally, impaired arteriogenesis in collaterals from other 
muscles may further impair the reactivity of PECs in the spinotrapezius. To test this, we could 
measure functional vasodilation at day-7 in the spinotrapezius of a C57BL/6, a strain with 
‘normal’ arteriogenesis, and compare to functional vasodilation in a spinotrapezius in a BALB/c 
muscle. By day-21, vasodilation of PECs in operated muscles surpassed that of contralateral 
sham-operated muscles in all regions except for the re-entry and midzone of females, indicating 
that most PECs exhibit mature vasodilation responses by day-21. Following arterial occlusion, 
males have a more robust eNOS-mediated vasodilation than females in response to 
acetylcholine, an endothlial-dependent dilator, which could explain why vasodilation in 
operated re-entry and midzone PECs in females was less than in males at day-7 [27]. 
Interestingly, females have higher levels of eNOS under baseline conditions, suggesting that 
eNOS activity is somehow decoupled from eNOS abundance [27]. But following surgery, a 
switch occurs and males have higher levels of eNOS [27], which may explain why males had 
greater vasodilation in collaterals following surgery. To test this hypothesis, an eNOS inhibitor 
could be applied after assessing functional vasodilation, and the amounts of vasodilation can be 
compared, to confirm that males have a more robust eNOS-mediated vasodilation than 
females. 
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As expected, functional vasodilation in ACCs was impaired at day-7, restored by day-21, and 
slightly improved with exercise, as determined by percent change in diameter. The decrease in 
functional vasodilation at day-7 was not surprising, based on previous reports of impaired 
endothelium-dependent and smooth muscle-dependent vasodilation in maturing collaterals 
[20,45]. However, since ACC reactivity is comparable in both endothelial-dependent and 
endothelial-independent vasodilation at day-7, this indicates that immature SMCs are likely 
responsible for the impairment, as they need time to arrange and mature into contractile SMCs 
[12]. Vessels regained vasodilation functionality by day-21, consistent with previous work from 
our group, demonstrating that functional vasodilation was impaired in immature vessels, but 
vessels exhibited mature responses by day-21 [12]. Capillaries generally are not surrounded by 
SMCs because dilation and constriction to regulate blood flow are typically not capillary 
functions, so most SMCs in ACCs are new to the area or recently differentiated from 
perivascular cells and likely need sufficient time to remodel and mature [12]. Exercise slightly 
improved vasodilation in ACCs, likely because exercise training improves endothelial-dependent 
dilation of collateral vessels by acutely elevating NO [29,47]. This could be confirmed by 
applying an eNOS inhibitor and determining if the effect disappears. There was a greater 
percent change in diameter in males than females at day-7 with exercise therapy, which is 
consistent with clinical data, suggesting that females respond less efficaciously to exercise 
therapy than males [35]. This may be due to NO-dependent endothelial dysfunction in females, 
which may not be overcome by acute elevation of NO with exercise [31]. 
 
In general, males and females had comparable vasodilation, but vasodilation was more 
impaired in females than males at day-7, as seen in ACCs, as males had a greater percent 
change in diameter at day-7 and at day-7 with exercise therapy, due to greater SMC relaxation. 
At baseline, there is no difference in the number of alpha-smooth muscle actin (alpha-SMA) 
positive vessels in female and male mice [27]. However, by day-7 post ligation, there is no 
change from baseline in the number of alpha-SMA positive vessels in females, but there is a 
significant increase in males [27]. The greater number of alpha-SMA-positive vessels in males 
may mean more arteriogenesis and capillary arterialization occurred, which may help explain 
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why vasodilation was more impaired in females than in males. Another important factor to 
consider relating to sex differences is estrogen. Estrogen activates and upregulates endothelial 
nitric oxide synthase (eNOS), increasing nitric oxide (NO) production that promotes smooth 
muscle cell relaxation [21]. Despite the protective role of estrogen, females with cardiovascular 
disease have a higher mortality rate than males, possibly because females are more susceptible 
to NO-dependent endothelial dysfunction than males, which may overpower the beneficial 
effects of estrogen [11]. Because arteriogenesis is regulated by NO, and NO significantly 
impacts vasomotor tone to enhance conductance of newly formed vessels, impaired eNOS 
signaling could explain the impairment  in vasodilation in female mice at day-7 [48]. This 
impairment in females is further supported by the fact that female mice had smaller resting 
diameters than males. However, by day-21, the percent change in diameter was greater in 
females than in males. Because shear induced vasodilation plays a large role in determining 
resting diameter [49], the small resting diameter but large percent change in females could be 
due to less basal NO and high levels of NO upon stimulation [27]. This could be confirmed by 
using an eNOS inhibitor, and measure functional vasodilation to compare diameters in females 
and males at rest and upon stimulation. 
 
Although the collateral circulation is the primary site of blood flow resistance, the 
microcirculation in the ischemic zone has a major contribution to the overall resistance to blood 
flow in the ischemic tree. Vasodilation was significantly impaired in the ischemic zone at day-7 
and resting diameters were elevated when compared to day-21. This outcome was expected, 
because ischemia impairs feed artery vasodilation by impairing the responsiveness of the 
vascular wall to vasodilation stimuli [50]. Because vessels had appropriate time to mature, 
vasodilation was recovered by day-21, and in some cases even surpassed that of control 
vessels, such as in first, second, and third-order arterioles in males. Interestingly, exercise had 
no impact on vasodilation in the ischemic zone at day-7. The loss of vascular tone at day-7 and 
day-7 with exercise is likely a result of high shear stress following occlusion, which increased NO 
production and caused vasodilation. To confirm the loss of vascular tone, we could apply a 
vasoconstrictor at day-7 to see if vessels are capable of constriction. If vasoconstriction 
 38 
capabilities are normal, and vessels have larger resting diameters than at day-21, vessels are 
likely actively vasodilating. Since the microcirculation in the ischemic zone has a major 
contribution to the overall resistance to blood flow in the ischemic tree, we can apply these 
results to better understand the time for recovery relative to other ischemic areas.  
 
Flow in collaterals is dependent upon input from the stem region because collaterals usually 
materialize from the second or third-order of the stem tree. As expected, functional 
vasodilation was impaired at day-7 in sedentary mice, but was similar to sham-operated mice at 
day-21. We expected vasodilation to be partially recovered at day-7 with exercise therapy, 
however, vasodilation was almost completely recovered, which might indicate that exercise 
therapy is more beneficial in the stem region than we predicted. This is not completely 
surprising, because following feed artery ligation, the significant increase in shear stress in the 
stem region leads to flow-induced vasodilation and subsequently outward remodeling [43], 
which might be enhanced with exercise, by providing additional NO, expediting arteriogenesis. 
Because following occlusion, all blood flow must go through the stem before reaching upstream 
vasculature in the spinotrapezius, we expect more relative remodeling. Exercise increased 
dilated first-order arteriole diameters in males and females, but it decreased both resting and 
dilated diameters in second-order arterioles in males, and resting diameters in third-order 
arterioles in males. This may be because first order stem arterioles are in a constant state of 
high flow for the first week following occlusion, which is further increased with exercise, 
because exercise increases levels of NO [29,51]. Second and third-order arterioles may have an 
opportunity to mature to a greater extent relative to first-order arterioles, since they are 
downstream of the stem vascular tree, and the blood flow is distributed among more vessels, 
which would allow them a chance to mature [51]. Because second and third-order arteriole 
resting diameters decreased with exercise only in males, it seems that exercise had a greater 
effect on males more than females.  
 
It is likely that the impairment in vasodilation in female mice seen in this study would be further 
exacerbated by the loss of estrogen following follicular loss in a future study. It is clear that 
estrogen plays an important role in PAOD etiology; the risk for reduction of vasodilation 
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becomes apparent at the age of menopause in women, more than a decade later than in men, 
suggesting a protective role of estrogen in cardiovascular disease etiology [20]. Postmenopausal 
women have higher levels of oxidative stress, insulin resistance, and inflammation when 
compared with men of a similar age, which may contribute to IC [20]. Additionally, chronic 
estrogen treatment preserves endothelium-dependent vasodilation in the peripheral 
vasculature of both ovariectomized rodents and post-menopausal women [20]. We saw more 
impaired vasodilation in female mice than in male mice in immature vessels, and female mice 
used in this study had intact ovaries. The loss of estrogen would likely more severely impair 
vasodilation in female mice. Clearly, sex differences in PAOD etiology should be carefully 
considered when considering novel disease treatments. 
 
The primary limitations of this study were that young and healthy mice were used which may 
not accurately represent co-morbidities commonly presented in patients with PAOD, 
measurement variation may exist in vessel diameters, the activity of individual mice in the 
exercise-trained groups cannot be determined due to housing limitations, and isolation housing 
may have decreased collateral remodeling.  
 
Our model of cardiovascular disease that utilizes young and healthy mice is limited, because 
vasculature is less reactive when co-morbidities are present, and co-morbidities are often 
present in patients presenting peripheral arterial occlusive disease [52]. The remodeled 
collaterals in this study are likely more robust and functional than they would be in mice with 
co-morbidities such as diabetes, hypertension, or post-menopause [52]. A clinically accurate 
representation of vessel reactivity and development could come from a diseased model of 
diabetes or hypertension developed through diet adjustment and/or genotyping. 
Understanding the differences in mechanisms by evaluating functional vasodilation in a 
diseased model would be advantageous in evaluating the efficacy of naturally remodeled 
collaterals. 
  
Although all vessel diameters within an anatomical position were averaged (i.e. 1st order 
ischemic tree), the average may not have accurately portrayed vessel diameters due to 
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measurement variation, and certain methods could be implemented in future experiments to 
further minimize this variation. Each vessel diameter was measured three times and the 
average was recorded, and each diameter measurement was slightly different, within half a 
micron for smaller vessels (ACCs), and within two microns for larger vessels (PECs, ischemic 
tree, and stem). This may have either increased or decreased average vessel diameters. Hand-
measurement is subjective, and a more controlled automated algorithm would be useful to 
eliminate measurement variability. Automatic vessel diameter measurement algorithms exist, 
such as an Unsupervised Linear Discriminant Analysis Diameter Measurement, which requires a 
user to identify the region of interest, then automatically separates the vessel from the 
background to obtain an accurate diameter measurement [53], or Rapid Analysis of Vessel 
Elements, which uses black and white pixels to differentiate between vessels and background, 
and counts pixels to make vessel diameter measurements [54]. These algorithms are very 
accurate and consistently performed better than most other techniques, and could be very 
useful to eliminate measurement error in future studies [53,54]. Additionally, blood flow and 
oxygen saturation levels could be measured using a technique called phosphorescence 
quenching in which oxygen quenches phosphor when oxygen molecules collide with phosphor 
and emits fluorescence [55]. Phosphorescence quenching could be used to map the oxygen 
pressure in the vasculature in vivo to determine if there is a correlation between blood flow 
and vasodilation [55]. 
 
Another limitation in this study is that the activity of individual mice in the exercise-trained 
groups cannot be determined. Because of this, we estimated the distance run by each animal as 
the total distance run for the entire cage divided by the number of mice in the cage.  If one 
mouse ran often and prevented the three others from running as much, the impact of exercise 
on functional vasodilation would not be accurately portrayed in the data. It is possible that if all 
four mice ran equally, we would see more of an impact on the data than we saw in this study, 
because the effects of exercise would be distributed amongst four data points rather than 
concentrated in one. In the future, this could be solved by adding a unique RFID tag to each 
mouse with a monitor on the exercise wheel, so rotations could be counted for each mouse 
individually. In addition, the inclusion of the running wheel tended to create aggression among 
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the animals, more commonly in male cages, as mice tended to appear possessive over the 
running wheel. For example, mice would knock a cage mate off the wheel to use it for 
themselves, and commonly we observed one mouse, possibly the dominant mouse, running 
while all others slept. If one mouse controlled the wheel and ran more than others, the 
potential effects of exercise on vasodilation would be maximized compared to the other mice. 
Aggression-induced stress may also have delayed vessel maturation during the recovery from 
chronic ischemia in sedentary mice [56]. Mice were group-housed with their original cage 
mates as much as possible following surgery, even if surgeries were 1 day apart. When 
surgeries were 1 day apart, existing mice became aggressive when vulnerable, recently-sedated 
mice were reintroduced into the cage. In cases of extreme aggression, the dominant mouse was 
isolation housed for the duration of recovery. Mice are social animals that do not respond well 
to isolation housing, which induces depression-like symptoms and signs of psychological stress 
[56]. In addition to psychological and behavioral responses, isolation housing affects the 
cardiovascular system, for example it increases blood pressure and heart rate in rats [57]. 
Therefore, it is possible that isolation housing decreased collateral remodeling in the current 
study, in the three mice that were isolation housed. Isolation housed mice had smaller 
collaterals than group-housed, however, since functional vasodilation was assessed on day-7 in 
all isolation housed mice, and vasodilation is significantly impaired at day-7 in ACCs and the 
ischemic zone, it is difficult to say if isolation housing had any effect on functional vasodilation.  
 
In conclusion, and despite these potential limitations, functional vasodilation is impaired in 
male BALB/c mice and female BALB/c mice in ACCs, PECs, the ischemic tree, and the stem, 7 
days following spinotrapezius feed artery ligation, and restored by day-21. This supports the 
hypothesis that impaired vasodilation may be involved in the pathophysiology of PAOD. 
Additionally, vasodilation in ACCs was more impaired in female mice than in males, and 
exercise training appears to enhance collateral reactivity, more in ACCs in males than in 
females, suggesting that its therapeutic benefits are linked not only to structural adaptation but 
also to vessel functionality. Therefore, future research is required to determine the cause of sex 
differences in exercise therapy to treat peripheral arterial occlusive disease. 
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Appendices 
Appendix A: Surgery and Experimental Protocols 
 
 
Date ______________ Spinotrapezius Ligation Initials____________ 
 
Mouse Information 
DOB: ______________________   
Sex: _______________________    
Tag: _______________________   
Genotype/strain: _____________  
Cage: ______________________   
Weight: _____________________  
 
Materials 
Instruments 
____1. Standard Pattern Forceps (1) 
____2. Iris Scissors (1) 
____3. S & T (2) 
____4. 5/45 (1) 
____5. Dumont #7’s (1) 
____6. Microdissection scissors (1) 
____7. Needle Holders (1) 
 
Pre-sterilize in autoclave 
____8. Cotton gauze (4) 
____9. Cotton swabs (4) 
____10. 6.0 silk suture (2x1 in) 
____11. Surgical Drape 
 
Obtained in surgery suite 
____12. Petri dish w/ sterile saline 
____13. Gloves 
____14. Sterile 7-0 prolene suture 
____15. FST heat pad w/ rectal probe 
____16. heat pad 
____17. Recovery bin and weigh boat 
____18. Depilatory cream 
____19. non-sterile cotton swabs 
____20. non-sterile cotton gauze 
____21. Isolation mask & cap 
____22. Analgesic (buprenorphine) 
 
Surgery Preparation 
____23. Spray surgery area with Nolvasan 
____24. Weigh animal in weight boat 
____25. Place animal in anesthesia box 
____26. Open the oxygen cylinder and set anesthesia-
machine flow meter to ~3 l·min-1 
____27. Anesthetize animal w/ 5% isoflurane  
____28. Reduce flow rate to 0.5-1.0 l·min-1 and the 
isoflurane to 1-3% 
____29. Lay animal prone with nose in nose-cone 
____30. Remove hair on anterior dorsal aspect of the 
animal with clippers and depilatory cream. 
____31. Apply vetinary ointment to eyes to avoid 
drying during the procedure 
____32. Give the animal subcutaneous injection of 
buprenorphine 
____33. Lay animal prone on circulating heat pad (w/ 
4x4 on top)  w/ nose in nose-cone 
____34. Insert rectal probe and set thermo-controller to 
35°C 
____35. Insert rectal probe and set thermo-controller to 
35 o C 
____36. Adjust focus, lighting, and center mouse 
____37. Don isolation mask, bonnet, and scrubs 
____38. Open sterile surgical instrument pack 
____39. Open sterile pack and dump in surgical 
instrument field 
____40. Place sterile petri dish in surgical field and fill 
with sterile saline 
____41. Don sterile gloves 
____42. Transfer the content of sterile pack to surgical 
instrument sterile field (leave 1 4x4 on bench 
for non-sterile hands) 
 
Surgery 
____43. Make 5mm incision parallel to spine at 
intersection of fat pad and muscle 
____44. Dissect skin overlying the spinotrapezius 
muscle 
____45. Search for lateral feed artery vein pair jumping 
from the underlying fat pad to the 
spinotrapezius 
____46. Blunt dissect fat pad to reveal arteriole-venule 
pair, using lidocaine as a vasodilator to aid in 
visualization 
____47. Blunt dissect arteriole away from venule 
____48. Pass a separated strand from 6-0 silk suture 
below the arteriole and tie off 
____49. Repeat again about 1mm above previous 
ligature 
____50. Cut arteriole between the two ligatures with 
micro dissection scissors 
____51. Suture incision with 7-0 prolene suture 
____52. Repeat for contralateral side to perform sham, 
but do not tie off ligature 
 
Post-Surgical 
____53. Give the animal a subcutaneous injection of 
buprenorphine 
____54. Place the animal in the recovery bin, on a blue 
bench cover, above a heat pad and allow to 
recover 
____55. Turn the flow meter down to 0, turn off the 
isoflurane, and close the oxygen cylinder 
____56. Indicate surgery on cage card. 
 
Notes 
 ________________________________ _______________  
 ________________________________ _______________  
 ________________________________ _______________  
 ________________________________ _______________  
 ________________________________ _______________  
 ________________________________ _______________  
 ________________________________ _______________  
 ________________________________ _______________  
 ________________________________ _______________  
 ________________________________ _______________  
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Functional Vasodilation Experimental Setup: 
 
 
 
Electrode Placement on the Spinotrapezius for Functional Vasodilation: 
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Appendix B: Sample Raw Images 
 
ACCs Day-7 Operated 
 
       
 
ACCs Day-7 Sham 
 
       
 
ACCs Day-21 Operated 
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ACCs Day-21 Sham 
 
       
 
ACCs Day-7 Exercise Operated 
 
       
 
ACCs Day-7 Exercise Sham 
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PECs Re-entry Day-7 Operated 
 
       
 
PECs Re-entry Day-7 Sham 
 
       
 
 
PECs Midzone Day-7 Operated 
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PECs Midzone Day-7 Sham 
 
       
 
PECs Stem Day-7 Operated 
 
       
 
PECs Stem Day-7 Sham 
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PECs Re-entry Day-21 Operated 
 
       
 
PECs Re-entry Day-21 Sham 
       
 
PECs Midzone Day-21 Operated 
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PECs Midzone Day-21 Sham 
 
       
 
PECs Stem Day-21 Operated 
 
       
PECs Stem Day-21 Sham 
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Ischemic Tree 1st Order Day-7 Operated 
 
       
 
Ischemic Tree 1st Order Day-7 Sham 
 
       
 
Ischemic Tree 2nd Order Day-7 Operated 
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Ischemic Tree 2nd Order Day-7 Sham 
 
       
 
Ischemic Tree 3rd Order Day-7 Operated 
 
       
 
Ischemic Tree 3rd Order Day-7 Sham 
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Ischemic Tree 1st Order Day-21 Operated 
 
       
 
Ischemic Tree 1st Order Day-21 Sham 
 
       
 
Ischemic Tree 2nd Order Day-21 Operated 
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Ischemic Tree 2nd Order Day-21 Sham 
 
       
 
Ischemic Tree 3rd Order Day-21 Operated 
 
       
 
Ischemic Tree 3rd Order Day-21 Sham 
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Ischemic Tree 1st Order Day-7 Exercise Operated 
 
       
 
Ischemic Tree 1st Order Day-7 Exercise Sham 
 
       
 
Ischemic Tree 2nd Order Day-7 Exercise Operated 
 
      
 
 60 
 
 
Ischemic Tree 2nd Order Day-7 Exercise Sham 
 
       
 
Ischemic Tree 3rd Order Day-7 Exercise Operated 
 
       
 
Ischemic Tree 3rd Order Day-7 Exercise Sham 
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Stem 1st Order Day-7 Operated 
 
       
 
Stem 1st Order Day-7 Sham 
 
       
 
Stem 2nd Order Day-7 Operated 
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Stem 2nd Order Day-7 Sham 
 
       
 
Stem 3rd Order Day-7 Operated 
 
       
 
Stem 3rd Order Day-7 Sham 
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Stem 1st Order Day-21 Operated 
 
       
 
Stem 1st Order Day-21 Sham 
 
       
 
Stem 2nd Order Day-21 Operated 
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Stem 2nd Order Day-21 Sham 
 
       
 
Stem 3rd Order Day-21 Operated 
 
       
 
Stem 3rd Order Day-21 Sham 
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Stem 1st Order Day-7 Exercise Operated 
 
       
 
Stem 1st Order Day-7 Exercise Sham 
 
       
 
Stem 2nd Order Day-7 Exercise Operated 
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Stem 2nd Order Day-7 Exercise Sham 
 
       
 
Stem 3rd Order Day-7 Exercise Operated 
 
       
 
Stem 3rd Order Day-7 Exercise Sham 
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Appendix C: Raw Data 
 
Sex Time Point Anatomical Location Limb 
Rest or 
Dilated? 
Mean 
Diameter 
Female Day-7 ACC Operated Resting 6.071 
Female Day-7 ACC Operated Dilated 6.382 
Female Day-7 ACC Sham Resting 5.817 
Female Day-7 ACC Sham Dilated 11.00 
Male Day-7 ACC Operated Resting 7.908 
Male Day-7 ACC Operated Dilated 8.662 
Male Day-7 ACC Sham Resting 7.407 
Male Day-7 ACC Sham Dilated 13.68 
Female Day-7 Exercise ACC Operated Resting 6.399 
Female Day-7 Exercise ACC Operated Dilated 7.585 
Female Day-7 Exercise ACC Sham Resting 6.582 
Female Day-7 Exercise ACC Sham Dilated 12.16 
Male Day-7 Exercise ACC Operated Resting 7.325 
Male Day-7 Exercise ACC Operated Dilated 9.396 
Male Day-7 Exercise ACC Sham Resting 7.206 
Male Day-7 Exercise ACC Sham Dilated 14.31 
Female Day-21 ACC Operated Resting 5.122 
Female Day-21 ACC Operated Dilated 10.22 
Female Day-21 ACC Sham Resting 5.961 
Female Day-21 ACC Sham Dilated 11.34 
Male Day-21 ACC Operated Resting 6.391 
Male Day-21 ACC Operated Dilated 11.92 
Male Day-21 ACC Sham Resting 6.888 
Male Day-21 ACC Sham Dilated 12.42 
Female Day-7 PEC - Re-entry Operated Resting 39.22 
Female Day-7 PEC - Re-entry Operated Dilated 60.07 
Female Day-7 PEC - Re-entry Sham Resting 26.43 
Female Day-7 PEC - Re-entry Sham Dilated 49.80 
Female Day-7 PEC - Midzone Operated Resting 27.53 
Female Day-7 PEC - Midzone Operated Dilated 40.86 
Female Day-7 PEC - Midzone Sham Resting 22.55 
Female Day-7 PEC - Midzone Sham Dilated 44.01 
Female Day-7 PEC - Stem Operated Resting 26.73 
Female Day-7 PEC - Stem Operated Dilated 39.96 
Female Day-7 PEC - Stem Sham Resting 17.32 
 
 68 
Sex Time Point Anatomical Location Limb 
Rest or 
Dilated? 
Mean 
Diameter 
Female Day-7 PEC - Stem Sham Dilated 33.67 
Male Day-7 PEC - Re-entry Operated Resting 39.09 
Male Day-7 PEC - Re-entry Operated Dilated 60.16 
Male Day-7 PEC - Re-entry Sham Resting 33.99 
Male Day-7 PEC - Re-entry Sham Dilated 61.28 
Male Day-7 PEC - Midzone Operated Resting 36.26 
Male Day-7 PEC - Midzone Operated Dilated 50.63 
Male Day-7 PEC - Midzone Sham Resting 23.23 
Male Day-7 PEC - Midzone Sham Dilated 47.37 
Male Day-7 PEC - Stem Operated Resting 34.01 
Male Day-7 PEC - Stem Operated Dilated 55.58 
Male Day-7 PEC - Stem Sham Resting 20.89 
Male Day-7 PEC - Stem Sham Dilated 41.28 
Female Day-21 PEC - Re-entry Operated Resting 26.84 
Female Day-21 PEC - Re-entry Operated Dilated 49.71 
Female Day-21 PEC - Re-entry Sham Resting 29.23 
Female Day-21 PEC - Re-entry Sham Dilated 64.67 
Female Day-21 PEC - Midzone Operated Resting 18.90 
Female Day-21 PEC - Midzone Operated Dilated 41.34 
Female Day-21 PEC - Midzone Sham Resting 22.59 
Female Day-21 PEC - Midzone Sham Dilated 51.21 
Female Day-21 PEC - Stem Operated Resting 17.99 
Female Day-21 PEC - Stem Operated Dilated 47.72 
Female Day-21 PEC - Stem Sham Resting 17.27 
Female Day-21 PEC - Stem Sham Dilated 39.45 
Male Day-21 PEC - Re-entry Operated Resting 31.00 
Male Day-21 PEC - Re-entry Operated Dilated 62.87 
Male Day-21 PEC - Re-entry Sham Resting 31.30 
Male Day-21 PEC - Re-entry Sham Dilated 58.39 
Male Day-21 PEC - Midzone Operated Resting 22.41 
Male Day-21 PEC - Midzone Operated Dilated 53.11 
Male Day-21 PEC - Midzone Sham Resting 28.15 
Male Day-21 PEC - Midzone Sham Dilated 53.03 
Male Day-21 PEC - Stem Operated Resting 21.44 
Male Day-21 PEC - Stem Operated Dilated 52.26 
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Sex Time Point Anatomical Location Limb 
Rest or 
Dilated? 
Mean 
Diameter 
Male Day-21 PEC - Stem Sham Resting 22.09 
Male Day-21 PEC - Stem Sham Dilated 42.85 
Female Day-7 Ischemic Tree - 1st Order Operated Resting 45.71 
Female Day-7 Ischemic Tree - 1st Order Operated Dilated 54.34 
Female Day-7 Ischemic Tree - 1st Order Sham Resting 26.43 
Female Day-7 Ischemic Tree - 1st Order Sham Dilated 49.80 
Female Day-7 Ischemic Tree - 2nd Order Operated Resting 31.96 
Female Day-7 Ischemic Tree - 2nd Order Operated Dilated 35.16 
Female Day-7 Ischemic Tree - 2nd Order Sham Resting 22.55 
Female Day-7 Ischemic Tree - 2nd Order Sham Dilated 44.01 
Female Day-7 Ischemic Tree - 3rd Order Operated Resting 25.44 
Female Day-7 Ischemic Tree - 3rd Order Operated Dilated 31.97 
Female Day-7 Ischemic Tree - 3rd Order Sham Resting 17.32 
Female Day-7 Ischemic Tree - 3rd Order Sham Dilated 33.67 
Male Day-7 Ischemic Tree - 1st Order Operated Resting 47.67 
Male Day-7 Ischemic Tree - 1st Order Operated Dilated 52.72 
Male Day-7 Ischemic Tree - 1st Order Sham Resting 33.99 
Male Day-7 Ischemic Tree - 1st Order Sham Dilated 61.28 
Male Day-7 Ischemic Tree - 2nd Order Operated Resting 40.46 
Male Day-7 Ischemic Tree - 2nd Order Operated Dilated 45.10 
Male Day-7 Ischemic Tree - 2nd Order Sham Resting 23.23 
Male Day-7 Ischemic Tree - 2nd Order Sham Dilated 47.37 
Male Day-7 Ischemic Tree - 3rd Order Operated Resting 23.83 
Male Day-7 Ischemic Tree - 3rd Order Operated Dilated 28.41 
Male Day-7 Ischemic Tree - 3rd Order Sham Resting 20.89 
Male Day-7 Ischemic Tree - 3rd Order Sham Dilated 41.28 
Female Day-21 Ischemic Tree - 1st Order Operated Resting 26.95 
Female Day-21 Ischemic Tree - 1st Order Operated Dilated 60.10 
Female Day-21 Ischemic Tree - 1st Order Sham Resting 29.23 
Female Day-21 Ischemic Tree - 1st Order Sham Dilated 64.67 
Female Day-21 Ischemic Tree - 2nd Order Operated Resting 20.12 
Female Day-21 Ischemic Tree - 2nd Order Operated Dilated 44.54 
Female Day-21 Ischemic Tree - 2nd Order Sham Resting 22.59 
Female Day-21 Ischemic Tree - 2nd Order Sham Dilated 51.21 
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Sex Time Point Anatomical Location Limb 
Rest or 
Dilated? 
Mean 
Diameter 
Female Day-21 Ischemic Tree - 3rd Order Operated Resting 20.11 
Female Day-21 Ischemic Tree - 3rd Order Operated Dilated 44.54 
Female Day-21 Ischemic Tree - 3rd Order Sham Resting 17.27 
Female Day-21 Ischemic Tree - 3rd Order Sham Dilated 39.45 
Male Day-21 Ischemic Tree - 1st Order Operated Resting 39.64 
Male Day-21 Ischemic Tree - 1st Order Operated Dilated 78.54 
Male Day-21 Ischemic Tree - 1st Order Sham Resting 31.30 
Male Day-21 Ischemic Tree - 1st Order Sham Dilated 58.39 
Male Day-21 Ischemic Tree - 2nd Order Operated Resting 30.12 
Male Day-21 Ischemic Tree - 2nd Order Operated Dilated 61.35 
Male Day-21 Ischemic Tree - 2nd Order Sham Resting 28.15 
Male Day-21 Ischemic Tree - 2nd Order Sham Dilated 53.03 
Male Day-21 Ischemic Tree - 3rd Order Operated Resting 22.27 
Male Day-21 Ischemic Tree - 3rd Order Operated Dilated 50.33 
Male Day-21 Ischemic Tree - 3rd Order Sham Resting 22.09 
Male Day-21 Ischemic Tree - 3rd Order Sham Dilated 42.85 
Female Day-7 Exercise Ischemic Tree - 1st Order Operated Resting 51.04 
Female Day-7 Exercise Ischemic Tree - 1st Order Operated Dilated 56.90 
Female Day-7 Exercise Ischemic Tree - 1st Order Sham Resting 34.64 
Female Day-7 Exercise Ischemic Tree - 1st Order Sham Dilated 56.66 
Female Day-7 Exercise Ischemic Tree - 2nd Order Operated Resting 37.16 
Female Day-7 Exercise Ischemic Tree - 2nd Order Operated Dilated 44.03 
Female Day-7 Exercise Ischemic Tree - 2nd Order Sham Resting 21.41 
Female Day-7 Exercise Ischemic Tree - 2nd Order Sham Dilated 38.54 
Female Day-7 Exercise Ischemic Tree - 3rd Order Operated Resting 29.31 
Female Day-7 Exercise Ischemic Tree - 3rd Order Operated Dilated 35.23 
Female Day-7 Exercise Ischemic Tree - 3rd Order Sham Resting 15.50 
Female Day-7 Exercise Ischemic Tree - 3rd Order Sham Dilated 28.12 
Male Day-7 Exercise Ischemic Tree - 1st Order Operated Resting 56.80 
Male Day-7 Exercise Ischemic Tree - 1st Order Operated Dilated 66.73 
Male Day-7 Exercise Ischemic Tree - 1st Order Sham Resting 34.65 
Male Day-7 Exercise Ischemic Tree - 1st Order Sham Dilated 63.14 
Male Day-7 Exercise Ischemic Tree - 2nd Order Operated Resting 41.83 
Male Day-7 Exercise Ischemic Tree - 2nd Order Operated Dilated 46.83 
Male Day-7 Exercise Ischemic Tree - 2nd Order Sham Resting 24.48 
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Sex Time Point Anatomical Location Limb 
Rest or 
Dilated? 
Mean 
Diameter 
Male Day-7 Exercise Ischemic Tree - 2nd Order Sham Dilated 49.31 
Male Day-7 Exercise Ischemic Tree - 3rd Order Operated Resting 26.45 
Male Day-7 Exercise Ischemic Tree - 3rd Order Operated Dilated 33.67 
Male Day-7 Exercise Ischemic Tree - 3rd Order Sham Resting 16.38 
Male Day-7 Exercise Ischemic Tree - 3rd Order Sham Dilated 32.00 
Female Day-7 Stem - 1st Order Operated Resting 42.20 
Female Day-7 Stem - 1st Order Operated Dilated 80.86 
Female Day-7 Stem - 1st Order Sham Resting 26.43 
Female Day-7 Stem - 1st Order Sham Dilated 49.80 
Female Day-7 Stem - 2nd Order Operated Resting 26.72 
Female Day-7 Stem - 2nd Order Operated Dilated 56.34 
Female Day-7 Stem - 2nd Order Sham Resting 22.55 
Female Day-7 Stem - 2nd Order Sham Dilated 44.01 
Female Day-7 Stem - 3rd Order Operated Resting 20.09 
Female Day-7 Stem - 3rd Order Operated Dilated 125.0 
Female Day-7 Stem - 3rd Order Sham Resting 17.32 
Female Day-7 Stem - 3rd Order Sham Dilated 33.67 
Male Day-7 Stem - 1st Order Operated Resting 49.22 
Male Day-7 Stem - 1st Order Operated Dilated 80.35 
Male Day-7 Stem - 1st Order Sham Resting 33.99 
Male Day-7 Stem - 1st Order Sham Dilated 61.28 
Male Day-7 Stem - 2nd Order Operated Resting 50.57 
Male Day-7 Stem - 2nd Order Operated Dilated 74.00 
Male Day-7 Stem - 2nd Order Sham Resting 23.23 
Male Day-7 Stem - 2nd Order Sham Dilated 47.37 
Male Day-7 Stem - 3rd Order Operated Resting 32.95 
Male Day-7 Stem - 3rd Order Operated Dilated 44.60 
Male Day-7 Stem - 3rd Order Sham Resting 20.89 
Male Day-7 Stem - 3rd Order Sham Dilated 41.28 
Female Day-21 Stem - 1st Order Operated Resting 34.56 
Female Day-21 Stem - 1st Order Operated Dilated 74.12 
Female Day-21 Stem - 1st Order Sham Resting 29.23 
Female Day-21 Stem - 1st Order Sham Dilated 64.67 
Female Day-21 Stem - 2nd Order Operated Resting 22.22 
Female Day-21 Stem - 2nd Order Operated Dilated 56.90 
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Sex Time Point Anatomical Location Limb 
Rest or 
Dilated? 
Mean 
Diameter 
Female Day-21 Stem - 2nd Order Sham Resting 22.59 
Female Day-21 Stem - 2nd Order Sham Dilated 51.21 
Female Day-21 Stem - 3rd Order Operated Resting 17.73 
Female Day-21 Stem - 3rd Order Operated Dilated 41.07 
Female Day-21 Stem - 3rd Order Sham Resting 17.27 
Female Day-21 Stem - 3rd Order Sham Dilated 39.45 
Male Day-21 Stem - 1st Order Operated Resting 39.53 
Male Day-21 Stem - 1st Order Operated Dilated 82.69 
Male Day-21 Stem - 1st Order Sham Resting 31.30 
Male Day-21 Stem - 1st Order Sham Dilated 58.39 
Male Day-21 Stem - 2nd Order Operated Resting 25.77 
Male Day-21 Stem - 2nd Order Operated Dilated 62.11 
Male Day-21 Stem - 2nd Order Sham Resting 28.15 
Male Day-21 Stem - 2nd Order Sham Dilated 53.03 
Male Day-21 Stem - 3rd Order Operated Resting 21.70 
Male Day-21 Stem - 3rd Order Operated Dilated 41.02 
Male Day-21 Stem - 3rd Order Sham Resting 22.09 
Male Day-21 Stem - 3rd Order Sham Dilated 42.85 
Female Day-7 Exercise Stem - 1st Order Operated Resting 45.03 
Female Day-7 Exercise Stem - 1st Order Operated Dilated 88.35 
Female Day-7 Exercise Stem - 1st Order Sham Resting 34.64 
Female Day-7 Exercise Stem - 1st Order Sham Dilated 56.66 
Female Day-7 Exercise Stem - 2nd Order Operated Resting 35.24 
Female Day-7 Exercise Stem - 2nd Order Operated Dilated 74.22 
Female Day-7 Exercise Stem - 2nd Order Sham Resting 21.41 
Female Day-7 Exercise Stem - 2nd Order Sham Dilated 38.54 
Female Day-7 Exercise Stem - 3rd Order Operated Resting 21.37 
Female Day-7 Exercise Stem - 3rd Order Operated Dilated 49.40 
Female Day-7 Exercise Stem - 3rd Order Sham Resting 15.50 
Female Day-7 Exercise Stem - 3rd Order Sham Dilated 28.12 
Male Day-7 Exercise Stem - 1st Order Operated Resting 44.81 
Male Day-7 Exercise Stem - 1st Order Operated Dilated 85.92 
Male Day-7 Exercise Stem - 1st Order Sham Resting 24.48 
Male Day-7 Exercise Stem - 1st Order Sham Dilated 49.31 
Male Day-7 Exercise Stem - 2nd Order Operated Resting 31.97 
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Sex Time Point Anatomical Location Limb 
Rest or 
Dilated? 
Mean 
Diameter 
Male Day-7 Exercise Stem - 2nd Order Operated Dilated 67.30 
Male Day-7 Exercise Stem - 2nd Order Sham Resting 24.48 
Male Day-7 Exercise Stem - 2nd Order Sham Dilated 49.31 
Male Day-7 Exercise Stem - 3rd Order Operated Resting 23.73 
Male Day-7 Exercise Stem - 3rd Order Operated Dilated 46.00 
Male Day-7 Exercise Stem - 3rd Order Sham Resting 16.38 
Male Day-7 Exercise Stem - 3rd Order Sham Dilated 31.99 
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Appendix D: Statistics  
Shapiro Wilk Normality Test: Resting Diameters: 
 
Sex Time Point Anatomical Location Limb P-value Normal? 
Female Day-7 ACC Operated 0.2861 Yes 
Female Day-7 ACC Sham 0.5828 Yes 
Male Day-7 ACC Operated 0.0539 Yes 
Male Day-7 ACC Sham 0.4571 Yes 
Female Day-21 ACC Operated 0.4785 Yes 
Female Day-21 ACC Sham 0.8173 Yes 
Male Day-21 ACC Operated 0.4980 Yes 
Male Day-21 ACC Sham 0.2628 Yes 
Female Day-7 Exercise ACC Operated 0.3439 Yes 
Female Day-7 Exercise ACC Sham 0.5776 Yes 
Male Day-7 Exercise ACC Operated 0.1443 Yes 
Male Day-7 Exercise ACC Sham 0.0190 No 
Female Day-7 PEC - Reentry Operated 0.7717 Yes 
Female Day-7 PEC - Midzone Operated 0.0934 Yes 
Female Day-7 PEC - Stem Operated 0.6579 Yes 
Female Day-7 1st Order Sham 0.3558 Yes 
Female Day-7 2nd Order Sham 0.3516 Yes 
Female Day-7 3rd Order Sham 0.4605 Yes 
Male Day-7 PEC - Reentry Operated 0.9340 Yes 
Male Day-7 PEC - Midzone Operated 0.1234 Yes 
Male Day-7 PEC - Stem Operated 0.2847 Yes 
Male Day-7 1st Order Sham 0.6698 Yes 
Male Day-7 2nd Order Sham 0.7995 Yes 
Male Day-7 3rd Order Sham 0.1399 Yes 
Female Day-21 PEC - Reentry Operated 0.1621 Yes 
Female Day-21 PEC - Midzone Operated 0.1104 Yes 
Female Day-21 PEC - Stem Operated 0.7354 Yes 
Female Day-21 Reentry Sham 0.3558 Yes 
Female Day-21 Midzone Sham 0.3516 Yes 
Female Day-21 Stem Sham 0.4605 Yes 
Male Day-21 PEC - Reentry Operated 0.0234 No 
Male Day-21 PEC - Midzone Operated 0.0581 Yes 
Male Day-21 PEC - Stem Operated 0.2634 Yes 
Male Day-21 Reentry Sham 0.9204 Yes 
Male Day-21 Midzone Sham 0.8076 Yes 
Male Day-21 Stem Sham 0.7947 Yes 
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Sex Time Point Anatomical Location Limb P-value Normal? 
Female Day-7 Ischemic Tree 1st Order Operated 0.4936 Yes 
Female Day-7 Ischemic Tree 2nd Order Operated 0.5285 Yes 
Female Day-7 Ischemic Tree 3rd Order Operated 0.7280 Yes 
Male Day-7 Ischemic Tree 1st Order Operated 0.2643 Yes 
Male Day-7 Ischemic Tree 2nd Order Operated 0.4820 Yes 
Male Day-7 Ischemic Tree 3rd Order Operated 0.8122 Yes 
Female Day-21 Ischemic Tree 1st Order Operated 0.2876 Yes 
Female Day-21 Ischemic Tree 2nd Order Operated 0.3094 Yes 
Female Day-21 Ischemic Tree 3rd Order Operated 0.6806 Yes 
Male Day-21 Ischemic Tree 1st Order Operated 0.6918 Yes 
Male Day-21 Ischemic Tree 2nd Order Operated 0.6944 Yes 
Male Day-21 Ischemic Tree 3rd Order Operated 0.0633 Yes 
Female Day-7 Exercise Ischemic Tree 1st Order Operated 0.4550 Yes 
Female Day-7 Exercise Ischemic Tree 2nd Order Operated 0.2600 Yes 
Female Day-7 Exercise Ischemic Tree 3rd Order Operated 0.4518 Yes 
Male Day-7 Exercise Ischemic Tree 1st Order Operated 0.0514 Yes 
Male Day-7 Exercise Ischemic Tree 2nd Order Operated 0.7095 Yes 
Male Day-7 Exercise Ischemic Tree 3rd Order Operated 0.6555 Yes 
Female Day-7 Stem 1st Order Operated 0.7601 Yes 
Female Day-7 Stem 2nd Order Operated 0.9521 Yes 
Female Day-7 Stem 3rd Order Operated 0.9949 Yes 
Male Day-7 Stem 1st Order Operated 0.1296 Yes 
Male Day-7 Stem 2nd Order Operated 0.0027 No 
Male Day-7 Stem 3rd Order Operated 0.4668 Yes 
Female Day-21 Stem 1st Order Operated 1.0000 Yes 
Female Day-21 Stem 2nd Order Operated 1.0000 Yes 
Female Day-21 Stem 3rd Order Operated 1.0000 Yes 
Male Day-21 Stem 1st Order Operated 0.2829 Yes 
Male Day-21 Stem 2nd Order Operated 0.0170 No 
Male Day-21 Stem 3rd Order Operated 0.3274 Yes 
Female Day-7 Exercise Stem 1st Order Operated 0.7757 Yes 
Female Day-7 Exercise Stem 2nd Order Operated 0.2188 Yes 
Female Day-7 Exercise Stem 3rd Order Operated 0.1919 Yes 
Male Day-7 Exercise Stem 1st Order Operated 0.1230 Yes 
Male Day-7 Exercise Stem 2nd Order Operated 0.5477 Yes 
Male Day-7 Exercise Stem 3rd Order Operated 0.3352 Yes 
Female Day-7 Exercise 1st Order Sham 0.5333 Yes 
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Sex Time Point Anatomical Location Limb P-value Normal? 
Female Day-7 Exercise 3rd Order Sham 0.0087 No 
Male Day-7 Exercise 1st Order Sham 0.8549 Yes 
Male Day-7 Exercise 2nd Order Sham 0.3629 Yes 
Male Day-7 Exercise 3rd Order Sham 0.1317 Yes 
 
 
 
Levene Test and Wilcoxon test: Resting diameters: 
 
Group 1 Group 2 
Levene    
P-value 
Equal 
variances? 
Wilcoxon    
P-value 
Different 
Means? 
ACC_M_D7Ex_Op ACC_M_D7Ex_Sham 0.8775 Yes 0.8463 No 
ACC_F_D7Ex_Sham ACC_M_D7Ex_Sham 0.6964 Yes 0.0821 No 
ACC_M_D7Ex_Sham ACC_M_D7_Sham 0.3837 Yes 0.5197 No 
PEC_M_D21_Reentry_Op PEC_M_D21_Reentry_Sham 0.3601 Yes 0.7469 No 
PEC_M_D21_Reentry_Op PEC_M_D21_Midzone_Op 0.9429 Yes 0.0169 Yes 
PEC_M_D21_Reentry_Op PEC_M_D21_Stem_Op 0.6890 Yes 0.0358 Yes 
PEC_F_D21_Reentry_Op PEC_M_D21_Reentry_Op 0.1294 Yes 0.8973 No 
PEC_M_D7_Reentry_Op PEC_M_D21_Reentry_Op 0.4354 Yes 0.0552 Yes 
Isch_F_D7Ex_3rdOrder_Op Isch_F_D7Ex_3rdOrder_Sham 0.7937 Yes 0.0200 Yes 
Stem_M_D7_2ndOrder_Op Stem_M_D7_2ndOrder_Sham 0.0158 No 0.0369 Yes 
Stem_M_D7_1stOrder_Op Stem_M_D7_2ndOrder_Op 0.9463 Yes 0.6625 No 
Stem_M_D7_2ndOrder_Op Stem_M_D7_3rdOrder_Op 0.1957 Yes 0.3827 No 
Stem_F_D7_2ndOrder_Op Stem_M_D7_2ndOrderOp 0.0895 Yes 0.0227 Yes 
Stem_M_D21_2ndOrder_Op Stem_M_D21_2ndOrder_Sham 0.6766 Yes 0.4113 No 
Stem_M_D21_1stOrder_Op Stem_M_D21_2ndOrder_Op 0.0598 Yes 0.0662 No 
Stem_M_D21_2ndOrder_Op Stem_M_D21_3rdOrder_Op 0.5841 Yes 0.7133 No 
Stem_F_D21_2ndOrder_Op Stem_M_D21_2ndOrder_Op 0.3841 Yes 1.0000 No 
Stem_M_D7_2ndOrder_Op Stem_M_D21_2ndOrder_Op 0.8424 Yes 0.7453 No 
Stem_F_D7Ex_3rdOrder_Op Stem_F_D7Ex_3rdOrder_Sham 0.0560 Yes 0.0122 Yes 
Stem_M_D7_2ndOrder_Op Stem_M_D7Ex_2ndOrder_Op 0.0311 Yes 0.0525 No 
F_D7_3rdOrder_Sham F_D7Ex_3rdOrder_Sham 0.0419 No 0.5498 No 
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F-test and ANOVA: Resting diameters: 
 
Group 1 Group 2 F-test 
Equal 
variances? 
ANOVA   
P-value 
Different 
means? 
ACC_F_D7_Op ACC_F_D7_Sham 0.6462 Yes 0.5614 No 
ACC_M_D7_Op ACC_M_D7_Sham 0.3181 Yes 0.3468 No 
ACC_F_D7_Op ACC_M_D7_Op 0.2715 Yes 0.0012 Yes 
ACC_F_D7_Sham ACC_M_D7_Sham 0.6655 Yes 0.0027 Yes 
ACC_F_D21_Op ACC_F_D21_Sham 0.7756 Yes 0.0960 No 
ACC_M_D21_Op ACC_M_D21_Sham 0.2612 Yes 0.4624 No 
ACC_F_D21_Op ACC_M_D21_Op 0.0791 Yes 0.0400 Yes 
ACC_F_D21_Sham ACC_M_D21_Sham 0.8896 Yes 0.1158 No 
ACC_F_D7Ex_Op ACC_F_D7Ex_Sham 0.3902 Yes 0.8123 No 
ACC_F_D7Ex_Op ACC_M_D7Ex_Op 0.3186 Yes 0.1705 No 
ACC_F_D7_Op ACC_F_D21_Op 0.6678 Yes 0.0213 Yes 
ACC_F_D7_Sham ACC_F_D21_Sham 0.8896 Yes 0.1158 No 
ACC_M_D7_Op ACC_M_D21_Op 0.4271 Yes 0.0483 Yes 
ACC_M_D7_Sham ACC_M_D21_Sham 0.4260 Yes 0.2888 No 
ACC_F_D7Ex_Op ACC_F_D7_Op 0.0636 Yes 0.5233 No 
ACC_F_D7Ex_Sham ACC_F_d7_Sham 0.8318 Yes 0.1719 No 
ACC_M_D7Ex_Op ACC_M_D7_Op 0.7472 Yes 0.3188 No 
PEC_F_D7_Reentry_Op PEC_F_D7_Reentry_Sham 0.0898 Yes 0.1758 No 
PEC_F_D7_Midzone_Op PEC_F_D7_Midzone_Sham 0.3773 Yes 0.3218 No 
PEC_F_D7_Stem_Op PEC_F_D7_Stem_Sham 0.3789 Yes 0.0283 Yes 
PEC_F_D7_Midzone_Op PEC_F_D7_Stem_Op 0.5776 Yes 0.7970 No 
PEC_M_D7_Reentry_Op PEC_M_D7_Reentry_Sham 0.8189 Yes 0.4251 No 
PEC_M_D7_Midzone_Op PEC_M_D7_Midzone_Sham 0.3122 Yes 0.0140 Yes 
PEC_M_D7_Stem_Op PEC_M_D7_Stem_Sham 0.2348 Yes 0.0827 No 
PEC_M_D7_Reentry_Op PEC_M_D7_Midzone_Op 0.8385 Yes 0.6149 No 
PEC_M_D7_Reentry_Op PEC_M_D7_Stem_Op 0.4824 Yes 0.4957 No 
PEC_M_D7_Midzone_Op PEC_M_D7_Stem_Op 0.3691 Yes 0.7524 No 
PEC_F_D7_Reentry_Op PEC_M_D7_Reentry_Op 0.1486 Yes 0.9895 No 
PEC_F_D7_Midzone_Op PEC_M_D7_Midzone_Op 0.4350 Yes 0.1007 No 
PEC_F_D7_Stem_Op PEC_M_D7_Stem_Op 0.0523 Yes 0.3213 No 
PEC_F_D21_Reentry_Op PEC_F_D21_Reentry_Sham 0.1401 Yes 0.6401 No 
PEC_F_D21_Midzone_Op PEC_F_D21_Midzone_Sham 0.8427 Yes 0.3837 No 
PEC_F_D21_Stem_Op PEC_F_D21_Stem_Sham 0.1928 Yes 0.8486 No 
PEC_F_D21_Reentry_Op PEC_F_D21_Midzone_Op 0.0880 Yes 0.0144 Yes 
PEC_F_D21_Reentry_Op PEC_F_D21_Stem_Op 0.2471 Yes 0.0542 No 
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Group 1 Group 2 F-test 
Equal 
variances? 
ANOVA   
P-value 
Different 
means? 
PEC_F_D21_Midzone_Op PEC_F_D21_Stem_Op 0.8530 Yes 0.8653 No 
PEC_M_D21_Midzone_Op PEC_M_D21_Midzone_Sham 0.6604 Yes 0.1418 No 
PEC_M_D21_Stem_Op PEC_M_D21_Stem_Sham 0.4820 Yes 0.8729 No 
PEC_M_D21_Midzone_Op PEC_M_D21_Stem_Op 0.4716 Yes 0.8003 No 
PEC_F_D21_Midzone_Op PEC_M_D21_Midzone_Op 0.9782 Yes 0.4093 No 
PEC_F_D21_Stem_Op PEC_M_D21_Stem_Op 0.4786 Yes 0.4452 No 
PEC_F_D7_Reentry_Op PEC_F_D21_Reentry_Op 0.3918 Yes 0.3827 No 
PEC_F_D7_Midzone_Op PEC_F_D21_Midzone_Op 0.5884 Yes 0.0745 No 
PEC_F_D7_Stem_Op PEC_F_D21_Stem_Op 0.2595 Yes 0.0811 No 
PEC_M_D7_Midzone_Op PEC_M_D21_Midzone_Op 0.7669 Yes 0.0085 Yes 
PEC_M_D7_Stem_Op PEC_M_D21_Stem_Op 0.0857 Yes 0.0800 No 
Isch_F_D7_2ndOrder_Op Isch_F_D7_2ndOrder_Sham 1.0000 Yes 0.0895 No 
Isch_F_D7_3rdOrder_Op Isch_F_D7_3rdOrder_Sham 0.2792 Yes 0.0732 No 
Isch_F_D7_1stOrder_Op Isch_F_D7_2ndOrder_Op 0.0722 Yes 0.2788 No 
Isch_F_D7_2ndOrder_Op Isch_F_D7_3rdOrder_Op 0.1512 Yes 0.2507 No 
Isch_M_D7_1stOrder_Op Isch_M_D7_1stOrder_Sham 0.7839 Yes 0.0932 No 
Isch_M_D7_2ndOrder_Op Isch_M_D7_2ndOrder_Sham 0.8468 Yes 0.0016 Yes 
Isch_M_D7_3rdOrder_Op Isch_M_D7_3rdOrder_Sham 0.2462 Yes 0.6844 No 
Isch_M_D7_1stOrder_Op Isch_M_D7_2ndOrder_Op 0.3808 Yes 0.2152 No 
Isch_M_D7_1stOrder_Op Isch_M_D7_3rdOrder_Op 0.5040 Yes 0.0533 No 
Isch_M_D7_2ndOrder_Op Isch_M_D7_3rdOrder_Op 0.1468 Yes 0.1027 No 
Isch_F_D7_1stOrder_Op Isch_M_D7_1stOrder_Op 0.1751 Yes 0.9018 No 
Isch_F_D7_2ndOrder_Op Isch_M_D7_2ndOrderOp 0.3356 Yes 0.1580 No 
Isch_F_D7_3rdOrder_Op Isch_M_D7_3rdOrder_Op 0.0639 Yes 0.8451 No 
Isch_F_D21_1stOrder_Op Isch_F_D21_1stOrder_Sham 0.2391 Yes 0.5977 No 
Isch_F_D21_2ndOrder_Op Isch_F_D21_2ndOrder_Sham 0.9059 Yes 0.5681 No 
Isch_F_D21_3rdOrder_Op Isch_F_D21_3rdOrder_Sham 0.2430 Yes 0.5116 No 
Isch_F_D21_1stOrder_Op Isch_F_D21_2ndOrder_Op 0.7717 Yes 0.2065 No 
Isch_F_D21_1stOrder_Op Isch_F_D21_3rdOrder_Op 0.8487 Yes 0.2580 No 
Isch_F_D21_2ndOrder_Op Isch_F_D21_3rdOrder_Op 0.9198 Yes 0.9315 No 
Isch_M_D21_1stOrder_Op Isch_M_D21_1stOrder_Sham 0.4696 Yes 0.1166 No 
Isch_M_D21_2ndOrder_Op Isch_M_D21_2ndOrder_Sham 0.6712 Yes 0.6052 No 
Isch_M_D21_3rdOrder_Op Isch_M_D21_3rdOrder_Sham 0.6105 Yes 0.9619 No 
Isch_M_D21_1stOrder_Op Isch_M_D21_2ndOrder_Op 0.1245 Yes 0.0011 Yes 
Isch_M_D21_1stOrder_Op Isch_M_D21_3rdOrder_Op 0.1516 Yes 0.0030 Yes 
Isch_M_D21_2ndOrder_Op Isch_M_D21_3rdOrder_Op 0.6160 Yes 0.0455 Yes 
Isch_F_D21_1stOrder_Op Isch_M_D21_1stOrder_Op 0.6531 Yes 0.0755 No 
Isch_F_D21_2ndOrder_Op Isch_M_D21_2ndOrder_Op 0.9321 Yes 0.0485 Yes 
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Group 1 Group 2 F-test 
Equal 
variances? 
ANOVA   
P-value 
Different  
means? 
Isch_F_D21_2ndOrder_Op Isch_M_D21_2ndOrder_Op 0.9321 Yes 0.0485 Yes 
Isch_F_D21_3rdOrder_Op Isch_M_D21_3rdOrder_Op 0.6976 Yes 0.5477 No 
Isch_F_D7_1stOrder_Op Isch_F_D21_1stOrder_Op 0.1020 Yes 0.2032 No 
Isch_F_D7_2ndOrder_Op Isch_F_D21_2ndOrder_Op 0.6981 Yes 0.0548 No 
Isch_F_D7_3rdOrder_Op Isch_F_D21_3rdOrder_Op 0.2339 Yes 0.2253 No 
Isch_M_D7_1stOrder_Op Isch_M_D21_1stOrder_Op 0.7247 Yes 0.2884 No 
Isch_M_D7_2ndOrder_Op Isch_M_D21_2ndOrder_Op 0.4433 Yes 0.0512 No 
Isch_M_D7_3rdOrder_Op Isch_M_D21_3rdOrder_Op 0.1030 Yes 0.7926 No 
Isch_F_D7Ex_1stOrder_Op Isch_F_D7Ex_1stOrder_Sham 0.3454 Yes 0.0002 Yes 
Isch_F_D7Ex_2ndOrder_Op Isch_F_D7Ex_2ndOrder_Sham 0.7960 Yes 0.0002 Yes 
Isch_F_D7Ex_1stOrder_Op Isch_F_D7Ex_2ndOrder_Op 0.7761 Yes 0.0006 Yes 
Isch_F_D7Ex_1stOrder_Op Isch_F_D7Ex_3rdOrder_Op 0.3800 Yes 0.0001 Yes 
Isch_F_D7Ex_2ndOrder_Op Isch_F_D7Ex_3rdOrder_Op 0.4985 Yes 0.0114 Yes 
Isch_M_D7Ex_1stOrder_Op Isch_M_D7Ex_1stOrder_Sham 1.0000 Yes 0.0001 Yes 
Isch_M_D7Ex_2ndOrder_Op Isch_M_D7Ex_2ndOrder_Sham 0.3736 Yes 0.0001 Yes 
Isch_M_D7Ex_3rdOrder_Op Isch_M_D7Ex_3rdOrder_Sham 0.1072 Yes 0.0073 Yes 
Isch_M_D7Ex_1stOrder_Op Isch_M_D7Ex_2ndOrder_Op 0.6046 Yes 0.0002 Yes 
Isch_M_D7Ex_1stOrder_Op Isch_M_D7Ex_3rdOrder_Op 0.9601 Yes 0.0001 Yes 
Isch_M_D7Ex_2ndOrder_Op Isch_M_D7Ex_3rdOrder_Op 0.5858 Yes 0.0003 Yes 
Isch_F_D7Ex_1stOrder_Op Isch_M_D7Ex_1stOrder_Op 0.6794 Yes 0.1069 No 
Isch_F_D7Ex_2ndOrder_Op Isch_M_D7Ex_2ndOrderOp 0.7837 Yes 0.0920 No 
Isch_F_D7Ex_3rdOrder_Op Isch_M_D7Ex_3rdOrder_Op 0.2136 Yes 0.4076 No 
Isch_F_D7_1stOrder_Op Isch_F_D7Ex_1stOrder_Op 0.0097 No 0.6383 No 
Isch_F_D7_2ndOrder_Op Isch_F_D7Ex_2ndOrder_Op 0.1592 Yes 0.2159 No 
Isch_F_D7_3rdOrder_Op Isch_F_D7Ex_3rdOrder_Op 0.9319 Yes 0.1069 No 
Isch_M_D7_1stOrder_Op Isch_M_D7Ex_1stOrder_Op 0.5506 Yes 0.0746 No 
Isch_M_D7_2ndOrder_Op Isch_M_D7Ex_2ndOrder_Op 0.8328 Yes 0.6754 No 
Isch_M_D7_1stOrder_Op Isch_M_D7Ex_1stOrder_Op 0.1429 Yes 0.6836 No 
Stem_F_D7_1stOrder_Op Stem_F_D7_1stOrder_Sham 0.6040 Yes 0.0176 Yes 
Stem_F_D7_2ndOrder_Op Stem_F_D7_2ndOrder_Sham 0.8589 Yes 0.3666 No 
Stem_F_D7_3rdOrder_Op Stem_F_D7_3rdOrder_Sham 0.7368 Yes 0.4338 No 
Stem_F_D7_1stOrder_Op Stem_F_D7_2ndOrder_Op 0.4229 Yes 0.0149 Yes 
Stem_F_D7_1stOrder_Op Stem_F_D7_3rdOrder_Op 0.1134 Yes 0.0015 Yes 
Stem_F_D7_2ndOrder_Op Stem_F_D7_3rdOrder_Op 0.3637 Yes 0.1110 No 
Stem_M_D7_1stOrder_Op Stem_M_D7_1stOrder_Sham 0.0907 Yes 0.2899 No 
Stem_M_D7_3rdOrder_Op Stem_M_D7_3rdOrder_Sham 0.5449 Yes 0.0765 No 
Stem_M_D7_1stOrder_Op Stem_M_D7_3rdOrder_Op 0.2018 Yes 0.3880 No 
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Group 1 Group 2 F-test 
Equal 
variances? 
ANOVA   
P-value 
Different 
means? 
Stem_F_D7_1stOrder_Op Stem_M_D7_1stOrder_Op 0.0951 Yes 0.5899 No 
Stem_F_D7_3rdOrder_Op Stem_M_D7_3rdOrder_Op 0.2592 Yes 0.0287 Yes 
Stem_F_D21_1stOrder_Op Stem_F_D21_1stOrder_Sham 0.0520 Yes 0.1491 No 
Stem_F_D21_2ndOrder_Op Stem_F_D21_2ndOrder_Sham 0.6556 Yes 0.9427 No 
Stem_F_D21_3rdOrder_Op Stem_F_D21_3rdOrder_Sham 1.0000 Yes 0.8734 No 
Stem_F_D21_1stOrder_Op Stem_F_D21_2ndOrder_Op 0.0641 Yes 0.0262 Yes 
Stem_F_D21_1stOrder_Op Stem_F_D21_3rdOrder_Op 0.0611 Yes 0.0157 Yes 
Stem_F_D21_2ndOrder_Op Stem_F_D21_3rdOrder_Op 0.9690 Yes 0.2673 No 
Stem_M_D21_1stOrder_Op Stem_M_D21_1stOrder_Sham 0.2386 Yes 0.2171 No 
Stem_M_D21_3rdOrder_Op Stem_M_D21_3rdOrder_Sham 0.5200 Yes 0.9298 No 
Stem_M_D21_1stOrder_Op Stem_M_D21_3rdOrder_Op 0.1160 Yes 0.0496 Yes 
Stem_F_D21_3rdOrder_Op Stem_M_D21_3rdOrder_Op 0.8567 Yes 0.3560 No 
Stem_F_D7_2ndOrder_Op Stem_F_D21_2ndOrder_Op 0.5367 Yes 0.4781 No 
Stem_F_D7_3rdOrder_Op Stem_F_D21_3rdOrder_Op 0.8258 Yes 0.5773 No 
Stem_M_D7_1stOrder_Op Stem_M_D21_1stOrder_Op 0.2812 Yes 0.5619 No 
Stem_M_D7_1stOrder_Op Stem_M_D21_1stOrder_Op 0.3040 Yes 0.0867 No 
Stem_F_D7Ex_1stOrder_Op Stem_F_D7Ex_1stOrder_Sham 0.4491 Yes 0.0020 Yes 
Stem_F_D7Ex_2ndOrder_Op Stem_F_D7Ex_2ndOrder_Sham 0.6730 Yes 0.0034 Yes 
Stem_F_D7Ex_1stOrder_Op Stem_F_D7Ex_2ndOrder_Op 0.5550 Yes 0.0171 Yes 
Stem_F_D7Ex_1stOrder_Op Stem_F_D7Ex_3rdOrder_Op 0.8196 Yes 0.0001 Yes 
Stem_F_D7Ex_2ndOrder_Op Stem_F_D7Ex_3rdOrder_Op 0.7148 Yes 0.0036 Yes 
Stem_M_D7Ex_1stOrder_Op Stem_M_D7Ex_1stOrder_Sham 0.4581 Yes 0.0516 No 
Stem_M_D7Ex_2ndOrder_Op Stem_M_D7Ex_2ndOrder_Sham 0.1476 Yes 0.0368 Yes 
Stem_M_D7Ex_3rdOrder_Op Stem_M_D7Ex_3rdOrder_Sham 0.4326 Yes 0.0028 Yes 
Stem_M_D7Ex_1stOrder_Op Stem_M_D7Ex_2ndOrder_Op 0.4430 Yes 0.0068 Yes 
Stem_M_D7Ex_2ndOrder_Op Stem_M_D7Ex_3rdOrder_Op 0.1704 Yes 0.0082 Yes 
Stem_F_D7Ex_1stOrder_Op Stem_M_D7Ex_1stOrder_Op 0.1800 Yes 0.9611 No 
Stem_F_D7Ex_2ndOrder_Op Stem_M_D7Ex_2ndOrderOp 0.8844 Yes 0.3834 No 
Stem_F_D7Ex_3rdOrder_Op Stem_M_D7Ex_3rdOrder_Op 0.5320 Yes 0.3456 No 
Stem_F_D7_1stOrder_Op Stem_F_D7Ex_1stOrder_Op 0.0839 Yes 0.6127 No 
Stem_F_D7_2ndOrder_Op Stem_F_D7Ex_2ndOrder_Op 0.5767 Yes 0.0719 No 
Stem_F_D7_3rdOrder_Op Stem_F_D7Ex_3rdOrder_Op 0.9166 Yes 0.6871 No 
Stem_M_D7_1stOrder_Op Stem_M_D7Ex_1stOrder_Op 0.0524 Yes 0.5916 No 
Stem_M_D7_1stOrder_Op Stem_M_D7Ex_1stOrder_Op 0.0613 Yes 0.0350 Yes 
F_D7_1stOrder_Sham M_D7_1stOrder_Sham 0.7668 Yes 0.2053 No 
F_D7_1stOrder_Sham F_D21_1stOrder_Sham 0.1549 Yes 0.5394 No 
M_D7_1stOrder_Sham M_D21_1stOrder_Sham 0.5862 Yes 0.6102 No 
 81 
 
 
Group 1 Group 2 F-test 
Equal 
variances? 
ANOVA   
P-value 
Different 
means? 
ACC_F_D7_Sham ACC_F_D21_Sham 0.8318 Yes 0.7784 No 
ACC_F_D7_Sham ACC_F_D7Ex_Sham 0.8318 Yes 0.1719 No 
ACC_M_D7_sham ACC_M_D21_Sham 0.4260 Yes 0.2888 No 
ACC_M_d7_Sham ACC_M_D7Ex_sham 0.7136 Yes 0.6485 No 
ACC_F_D7_Sham ACC_M_d7_Sham 0.6655 Yes 0.0027 Yes 
ACC_F_D7Ex_Sham ACC_M_D7Ex_sham 0.8072 Yes 0.2698 No 
ACC_F_D21_Sham ACC_M_D21_Sham 0.8896 Yes 0.1158 No 
F_D7_2ndOrder_Sham M_D7_2ndOrder_Sham 0.2516 Yes 0.8766 No 
F_D7_2ndOrder_Sham F_D21_2ndOrder_Sham 0.5291 Yes 0.9928 No 
M_D7_2ndOrder_Sham M_D21_2ndOrder_Sham 0.6637 Yes 0.1654 No 
F_D7_2ndOrder_Sham F_D7Ex_2ndOrder_Sham 0.2602 Yes 0.7962 No 
F_D7_3rdOrder_Sham M_D7_3rdOrder_Sham 0.8175 Yes 0.4068 No 
F_D7_3rdOrder_Sham F_D21_3rdOrder_Sham 1.0000 Yes 1.0000 No 
M_D7_3rdOrder_Sham M_D21_3rdOrder_Sham 0.9166 Yes 0.7949 No 
M_D7_2ndOrder_Sham M_D7Ex_2ndOrder_Sham 0.4124 Yes 0.6272 No 
M_D7_3rdOrder_Sham M_D7Ex_3rdOrder_Sham 0.0750 Yes 0.2028 No 
 
 
 
F-test and Welch (Resting diameters): 
 
Group 1 Group 2 
F-test 
value 
Equal 
variances? 
ANOVA 
P-value 
Different 
means? 
PEC_F_D7_Reentry_Op PEC_F_D7_Midzone_Op 0.0424 No 0.3376 No 
PEC_F_D7_Reentry_Op PEC_F_D7_Stem_Op 0.0155 No 0.3084 No 
Isch_F_D7_1stOrder_Op Isch_F_D7_1stOrder_Sham 0.0485 No 0.3065 No 
Isch_F_D7_1stOrder_Op Isch_F_D7_3rdOrder_Op 0.0186 No 0.2898 No 
Stem_F_D21_1stOrder_Op Stem_M_D21_1stOrder_Op 0.0155 No 0.5217 No 
Stem_F_D7_1stOrder_Op Stem_F_D21_1stOrder_Op 0.0194 No 0.1593 No 
Stem_M_D7Ex_1stOrder_Op Stem_M_D7Ex_3rdOrder_Op 0.0410 No 0.0004 Yes 
F_D7_1stOrder_Sham F_D7Ex_1stOrder_Sham 0.0422 No 0.0573 No 
 
 
 
 
 
 
 82 
Shapiro Wilk Normality Test: Dilated diameters: 
 
Sex Time Point Anatomical Location Limb P-value Normal? 
Female Day-7 ACC Operated 0.2932 Yes 
Female Day-7 ACC Sham 0.3895 Yes 
Male Day-7 ACC Operated 0.0150 No 
Male Day-7 ACC Sham 0.2816 Yes 
Female Day-21 ACC Operated 0.0036 No 
Female Day-21 ACC Sham 0.6560 Yes 
Male Day-21 ACC Operated 0.2231 Yes 
Male Day-21 ACC Sham 0.3968 Yes 
Female Day-7 Exercise ACC Operated 0.2397 Yes 
Female Day-7 Exercise ACC Sham 0.7427 Yes 
Male Day-7 Exercise ACC Operated 0.7550 Yes 
Male Day-7 Exercise ACC Sham 0.3598 Yes 
Female Day-7 PEC - Reentry Operated 0.8427 Yes 
Female Day-7 PEC - Midzone Operated 0.9666 Yes 
Female Day-7 PEC - Stem Operated 0.7669 Yes 
Female Day-7 Reentry Sham 0.4935 Yes 
Female Day-7 Midzone Sham 0.8464 Yes 
Female Day-7 Stem Sham 0.4508 Yes 
Male Day-7 PEC - Reentry Operated 0.8319 Yes 
Male Day-7 PEC - Midzone Operated 0.3638 Yes 
Male Day-7 PEC - Stem Operated 0.9473 Yes 
Male Day-7 Reentry Sham 0.5286 Yes 
Male Day-7 Midzone Sham 0.1288 Yes 
Male Day-7 Stem Sham 0.0870 Yes 
Female Day-21 PEC - Reentry Operated 0.1143 Yes 
Female Day-21 PEC - Midzone Operated 0.2684 Yes 
Female Day-21 PEC - Stem Operated 0.6723 Yes 
Female Day-21 Reentry Sham 0.4935 Yes 
Female Day-21 Midzone Sham 0.8464 Yes 
Female Day-21 Stem Sham 0.4508 Yes 
Male Day-21 PEC - Reentry Operated 0.3750 Yes 
Male Day-21 PEC - Midzone Operated 0.7027 Yes 
Male Day-21 PEC - Stem Operated 0.0922 Yes 
Male Day-21 Reentry Sham 0.7621 Yes 
Male Day-21 Midzone Sham 0.4791 Yes 
Male Day-21 Stem Sham 0.8988 Yes 
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Sex Time Point Anatomical Location Limb P-value Normal? 
Female Day-7 Ischemic Tree 1st Order Operated 0.2750 Yes 
Female Day-7 Ischemic Tree 2nd Order Operated 0.1384 Yes 
Female Day-7 Ischemic Tree 3rd Order Operated 0.1210 Yes 
Male Day-7 Ischemic Tree 1st Order Operated 0.2830 Yes 
Male Day-7 Ischemic Tree 2nd Order Operated 0.7815 Yes 
Male Day-7 Ischemic Tree 3rd Order Operated 0.8345 Yes 
Female Day-21 Ischemic Tree 1st Order Operated 0.0698 Yes 
Female Day-21 Ischemic Tree 2nd Order Operated 0.6904 Yes 
Female Day-21 Ischemic Tree 3rd Order Operated 0.4297 Yes 
Male Day-21 Ischemic Tree 1st Order Operated 0.6371 Yes 
Male Day-21 Ischemic Tree 2nd Order Operated 0.1022 Yes 
Male Day-21 Ischemic Tree 3rd Order Operated 0.4124 Yes 
Female Day-7 Exercise Ischemic Tree 1st Order Operated 0.7217 Yes 
Female Day-7 Exercise Ischemic Tree 2nd Order Operated 0.9740 Yes 
Female Day-7 Exercise Ischemic Tree 3rd Order Operated 0.9588 Yes 
Male Day-7 Exercise Ischemic Tree 1st Order Operated 0.1194 Yes 
Male Day-7 Exercise Ischemic Tree 2nd Order Operated 0.2260 Yes 
Male Day-7 Exercise Ischemic Tree 3rd Order Operated 0.8511 Yes 
Female Day-7 Stem 1st Order Operated 0.6215 Yes 
Female Day-7 Stem 2nd Order Operated 0.2857 Yes 
Female Day-7 Stem 3rd Order Operated 0.0787 Yes 
Male Day-7 Stem 1st Order Operated 0.6875 Yes 
Male Day-7 Stem 2nd Order Operated 0.5488 Yes 
Male Day-7 Stem 3rd Order Operated 0.0473 No 
Female Day-21 Stem 1st Order Operated 1.0000 Yes 
Female Day-21 Stem 2nd Order Operated 1.0000 Yes 
Female Day-21 Stem 3rd Order Operated 1.0000 Yes 
Male Day-21 Stem 1st Order Operated 0.7299 Yes 
Male Day-21 Stem 2nd Order Operated 0.6404 Yes 
Male Day-21 Stem 3rd Order Operated 0.2509 Yes 
Female Day-7 Exercise Stem 1st Order Operated 0.0921 Yes 
Female Day-7 Exercise Stem 2nd Order Operated 0.7121 Yes 
Female Day-7 Exercise Stem 3rd Order Operated 0.2504 Yes 
Male Day-7 Exercise Stem 1st Order Operated 0.1580 Yes 
Male Day-7 Exercise Stem 2nd Order Operated 0.1366 Yes 
Male Day-7 Exercise Stem 3rd Order Operated 0.3255 Yes 
Female Day-7 Exercise 1st Order Sham 0.7211 Yes 
Female Day-7 Exercise 2nd Order Sham 0.1305 Yes 
Female Day-7 Exercise 3rd Order Sham 0.0397 No 
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Sex Time Point Anatomical Location Limb P-value Normal? 
Male Day-7 Exercise 1st Order Sham 0.0085 No 
Male Day-7 Exercise 2nd order Sham 0.6633 Yes 
Male Day-7 Exercise 3rd Order Sham 0.7104 Yes 
 
 
Levene’s test for equal variances and Wilcoxon test: Dilated diameters: 
 
Group 1 Group 2 
Levene    
P-value 
Equal 
Variances? 
Wilcoxon    
P-value 
Different 
Means? 
ACC_M_D7_Op ACC_M_D7_Sham 0.5493 Yes 0.0034 Yes 
ACC_F_D7_Op ACC_M_D7_Op 0.0157 No 0.0120 Yes 
ACC_F_D21_Op ACC_F_D21_Sham 0.9449 Yes 0.1749 No 
ACC_F_D21_Op ACC_M_D21_Op 0.1408 Yes 0.1701 No 
ACC_F_D7_Op ACC_F_D21_Op 0.2044 Yes 0.0004 Yes 
ACC_M_D7_Op ACC_M_D21_Op 0.1018 Yes 0.0027 Yes 
ACC_M_D7Ex_Op ACC_M_D7_Op 0.7796 Yes 0.4772 No 
Isch_F_D7Ex_3rdOrder_Op Isch_F_D7Ex_3rdOrder_Sham 0.2694 Yes 0.1113 No 
Isch_M_D7Ex_1stOrder_Op Isch_M_D7Ex_1stOrder_Sham 0.6392 Yes 0.1939 No 
Stem_M_D7_3rdOrder_Op Stem_M_D7_3rdOrder_Sham 0.6511 Yes 1.0000 No 
Stem_M_D7_1stOrder_Op Stem_M_D7_3rdOrder_Op 0.4020 Yes 0.0809 No 
Stem_M_D7_2ndOrder_Op Stem_M_D7_3rdOrder_Op 0.3630 Yes 0.0809 No 
Stem_F_D7_3rdOrder_Op Stem_M_D7_3rdOrder_Op 0.8432 Yes 0.8973 No 
Stem_F_D7Ex_3rdOrder_Op Stem_F_D7Ex_3rdOrder_Sham 0.0688 Yes 0.0122 Yes 
Stem_M_D7Ex_1stOrder_Op Stem_M_D7Ex_1stOrder_Sham 0.7972 Yes 0.0149 Yes 
Stem_M_D7_3rdOrder_Op Stem_M_D7Ex_3rdOrder_Op 0.1022 Yes 0.9185 No 
F_D7_3rdOrder_Sham F_D7Ex_3rdOrder_Sham 0.1002 Yes 0.2963 No 
M_D7Ex_1stOrder_Sham M_D7_1stOrder_Sham 0.7462 Yes 0.8345 No 
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F-test and ANOVA (Dilated diameters): 
 
Group 1 Group 2 F-test 
Equal 
variances? 
ANOVA       
P-value 
Different 
means? 
ACC_F_D7_Op ACC_F_D7_Sham 0.1152 Yes 0.0001 Yes 
ACC_F_D7_Sham ACC_M_D7_Sham 0.5683 Yes 0.0021 Yes 
ACC_M_D21_Op ACC_M_D21_Sham 0.3721 Yes 0.6769 No 
ACC_F_D21_Sham ACC_M_D21_Sham 0.8617 Yes 0.3200 No 
ACC_F_D7Ex_Op ACC_F_D7Ex_Sham 0.9283 Yes 0.0011 Yes 
ACC_M_D7Ex_Op ACC_M_D7Ex_Sham 0.5534 Yes 0.0001 Yes 
ACC_F_D7Ex_Op ACC_M_D7Ex_Op 0.5070 Yes 0.0439 Yes 
ACC_F_D7Ex_Sham ACC_M_D7Ex_Sham 0.9580 Yes 0.0653 No 
ACC_F_D7_Sham ACC_F_D21_Sham 0.6284 Yes 0.7040 No 
ACC_M_D7_Sham ACC_M_D21_Sham 0.2156 Yes 0.1596 No 
ACC_F_D7Ex_Sham ACC_F_D7_Sham 0.7223 Yes 0.2219 No 
ACC_M_D7Ex_Sham ACC_M_D7_Sham 0.3269 Yes 0.4448 No 
PEC_F_D7_Reentry_Op PEC_F_D7_Reentry_Sham 0.1752 Yes 0.4589 No 
PEC_F_D7_Midzone_Op PEC_F_D7_Midzone_Sham 0.9584 Yes 0.7237 No 
PEC_F_D7_Stem_Op PEC_F_D7_Stem_Sham 0.7675 Yes 0.3764 No 
PEC_F_D7_Reentry_Op PEC_F_D7_Midzone_Op 0.2134 Yes 0.2758 No 
PEC_F_D7_Reentry_Op PEC_F_D7_Stem_Op 0.0773 Yes 0.2366 No 
PEC_F_D7_Midzone_Op PEC_F_D7_Stem_Op 0.5342 Yes 0.9124 No 
PEC_M_D7_Reentry_Op PEC_M_D7_Reentry_Sham 0.1093 Yes 0.8497 No 
PEC_M_D7_Midzone_Op PEC_M_D7_Midzone_Sham 0.7240 Yes 0.5527 No 
PEC_M_D7_Stem_Op PEC_M_D7_Stem_Sham 0.5572 Yes 0.1271 No 
PEC_M_D7_Reentry_Op PEC_M_D7_Midzone_Op 0.4128 Yes 0.0441 Yes 
PEC_M_D7_Midzone_Op PEC_M_D7_Stem_Op 0.2023 Yes 0.5318 No 
PEC_F_D7_Midzone_Op PEC_M_D7_Midzone_Op 0.3189 Yes 0.1966 No 
PEC_F_D7_Stem_Op PEC_M_D7_Stem_Op 0.3925 Yes 0.1120 No 
PEC_F_D21_Reentry_Op PEC_F_D21_Reentry_Sham 0.1559 Yes 0.1651 No 
PEC_F_D21_Midzone_Op PEC_F_D21_Midzone_Sham 0.2585 Yes 0.3733 No 
PEC_F_D21_Stem_Op PEC_F_D21_Stem_Sham 0.0902 Yes 0.4521 No 
PEC_F_D21_Reentry_Op PEC_F_D21_Midzone_Op 0.9462 Yes 0.6056 No 
PEC_F_D21_Reentry_Op PEC_F_D21_Stem_Op 0.8734 Yes 0.9110 No 
PEC_F_D21_Midzone_Op PEC_F_D21_Stem_Op 1.0000 Yes 0.7030 No 
PEC_M_D21_Reentry_Op PEC_M_D21_Reentry_Sham 0.7355 Yes 0.5660 No 
PEC_M_D21_Midzone_Op PEC_M_D21_Midzone_Sham 0.4622 Yes 0.9900 No 
PEC_M_D21_Stem_Op PEC_M_D21_Stem_Sham 0.9156 Yes 0.2755 No 
PEC_M_D21_Reentry_Op PEC_M_D21_Midzone_Op 0.9235 Yes 0.1933 No 
PEC_M_D21_Reentry_Op PEC_M_D21_Stem_Op 0.9169 Yes 0.2055 No 
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Group 1 Group 2 F-test 
Equal 
variances? 
ANOVA       
P-value 
Different 
means? 
PEC_M_D21_Midzone_Op PEC_M_D21_Stem_Op 1.0000 Yes 0.9133 No 
PEC_F_D21_Reentry_Op PEC_M_D21_Reentry_Op 0.3963 Yes 0.2478 No 
PEC_F_D21_Midzone_Op PEC_M_D21_Midzone_Op 0.2443 Yes 0.2509 No 
PEC_F_D21_Stem_Op PEC_M_D21_Stem_Op 0.3557 Yes 0.7184 No 
PEC_F_D7_Reentry_Op PEC_F_D21_Reentry_Op 0.6221 Yes 0.6202 No 
PEC_F_D7_Midzone_Op PEC_F_D21_Midzone_Op 0.4141 Yes 0.9701 No 
PEC_F_D7_Stem_Op PEC_F_D21_Stem_Op 0.1743 Yes 0.5352 No 
PEC_M_D7_Reentry_Op PEC_M_D21_Reentry_Op 0.0859 Yes 0.6642 No 
PEC_M_D7_Midzone_Op PEC_M_D21_Midzone_Op 0.2776 Yes 0.7164 No 
PEC_M_D7_Reentry_Op PEC_M_D21_Reentry_Op 0.7808 Yes 0.7207 No 
Isch_F_D7_1stOrder_Op Isch_F_D7_1stOrder_Sham 0.4435 Yes 0.7143 No 
Isch_F_D7_2ndOrder_Op Isch_F_D7_2ndOrder_Sham 0.2897 Yes 0.2399 No 
Isch_F_D7_3rdOrder_Op Isch_F_D7_3rdOrder_Sham 0.5055 Yes 0.8130 No 
Isch_F_D7_1stOrder_Op Isch_F_D7_2ndOrder_Op 0.0909 Yes 0.1134 No 
Isch_F_D7_1stOrder_Op Isch_F_D7_3rdOrder_Op 0.1415 Yes 0.1615 No 
Isch_F_D7_2ndOrder_Op Isch_F_D7_3rdOrder_Op 0.7811 Yes 0.5768 No 
Isch_M_D7_1stOrder_Op Isch_M_D7_1stOrder_Sham 0.4491 Yes 0.2998 No 
Isch_M_D7_2ndOrder_Op Isch_M_D7_2ndOrder_Sham 0.4628 Yes 0.7076 No 
Isch_M_D7_3rdOrder_Op Isch_M_D7_3rdOrder_Sham 0.4866 Yes 0.2198 No 
Isch_M_D7_1stOrder_Op Isch_M_D7_2ndOrder_Op 0.7537 Yes 0.1672 No 
Isch_M_D7_1stOrder_Op Isch_M_D7_3rdOrder_Op 0.2637 Yes 0.0688 No 
Isch_M_D7_2ndOrder_Op Isch_M_D7_3rdOrder_Op 0.1682 Yes 0.1562 No 
Isch_F_D7_1stOrder_Op Isch_M_D7_1stOrder_Op 0.1492 Yes 0.9074 No 
Isch_F_D7_2ndOrder_Op Isch_M_D7_2ndOrderOp 0.5635 Yes 0.1041 No 
Isch_F_D7_3rdOrder_Op Isch_M_D7_3rdOrder_Op 0.2508 Yes 0.7347 No 
Isch_F_D21_1stOrder_Op Isch_F_D21_1stOrder_Sham 0.2101 Yes 0.6093 No 
Isch_F_D21_2ndOrdere_Op Isch_F_D21_2ndOrder_Sham 0.7773 Yes 0.4559 No 
Isch_F_D21_3rdOrder_Op Isch_F_D21_3rdOrder_Sham 0.4180 Yes 0.7781 No 
Isch_F_D21_1stOrder_Op Isch_F_D21_2ndOrder_Op 0.7375 Yes 0.2340 No 
Isch_F_D21_1stOrder_Op Isch_F_D21_3rdOrder_Op 0.7264 Yes 0.1705 No 
Isch_F_D21_2ndOrder_Op Isch_F_D21_3rdOrder_Op 0.9173 Yes 0.7796 No 
Isch_M_D21_1stOrder_Op Isch_M_D21_1stOrder_Sham 0.3609 Yes 0.0530 No 
Isch_M_D21_2ndOrder_Op Isch_M_D21_2ndOrder_Sham 0.3341 Yes 0.0844 No 
Isch_M_D21_3rdOrder_Op Isch_M_D21_3rdOrder_Sham 0.7710 Yes 0.2964 No 
Isch_M_D21_1stOrder_Op Isch_M_D21_2ndOrder_Op 0.7247 Yes 0.0001 Yes 
Isch_M_D21_1stOrder_Op Isch_M_D21_3rdOrder_Op 0.1304 Yes 0.0095 Yes 
Isch_M_D21_2ndOrder_Op Isch_M_D21_3rdOrder_Op 0.1872 Yes 0.0408 Yes 
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Group 1 Group 2 F-test 
Equal 
variances? 
ANOVA       
P-value 
Different 
means? 
Isch_F_D21_1stOrder_Op Isch_M_D21_1stOrder_Op 0.7391 Yes 0.1774 No 
Isch_F_D21_2ndOrder_Op Isch_M_D21_2ndOrder_Op 0.0869 Yes 0.0208 Yes 
Isch_F_D21_3rdOrder_Op Isch_M_D21_3rdOrder_Op 0.7172 Yes 0.2945 No 
Isch_F_D7_1stOrder_Op Isch_F_D21_1stOrder_Op 0.6528 Yes 0.7078 No 
Isch_F_D7_2ndOrder_Op Isch_F_D21_2ndOrder_Op 0.3055 Yes 0.2454 No 
Isch_F_D7_3rdOrder_Op Isch_F_D21_3rdOrder_Op 0.3878 Yes 0.2920 No 
Isch_M_D7_1stOrder_Op Isch_M_D21_1stOrder_Op 0.1561 Yes 0.0832 No 
Isch_M_D7_2ndOrder_Op Isch_M_D21_2ndOrder_Op 0.8382 Yes 0.0040 Yes 
Isch_M_D7_1stOrder_Op Isch_M_D21_1stOrder_Op 0.4190 Yes 0.0341 Yes 
Isch_F_D7Ex_1stOrder_Op Isch_F_D7Ex_1stOrder_Sham 0.4593 Yes 0.9477 No 
Isch_F_D7Ex_2ndOrder_Op Isch_F_D7Ex_2ndOrder_Sham 0.1697 Yes 0.0855 No 
Isch_F_D7Ex_1stOrder_Op Isch_F_D7Ex_2ndOrder_Op 0.4458 Yes 0.0003 Yes 
Isch_F_D7Ex_1stOrder_Op Isch_F_D7Ex_3rdOrder_Op 0.3767 Yes 0.0001 Yes 
Isch_F_D7Ex_2ndOrder_Op Isch_F_D7Ex_3rdOrder_Op 0.7802 Yes 0.0016 Yes 
Isch_M_D7Ex_2ndOrder_Op Isch_M_D7Ex_2ndOrder_Sham 0.7941 Yes 0.3693 No 
Isch_M_D7Ex_3rdOrder_Op Isch_M_D7Ex_3rdOrder_Sham 0.3001 Yes 0.6855 No 
Isch_M_D7Ex_1stOrder_Op Isch_M_D7Ex_2ndOrder_Op 0.3390 Yes 0.0001 Yes 
Isch_M_D7Ex_1stOrder_Op Isch_M_D7Ex_3rdOrder_Op 0.6449 Yes 0.0001 Yes 
Isch_M_D7Ex_2ndOrder_Op Isch_M_D7Ex_3rdOrder_Op 0.1720 Yes 0.0030 Yes 
Isch_F_D7Ex_1stOrder_Op Isch_M_D7Ex_1stOrder_Op 0.4838 Yes 0.0160 Yes 
Isch_F_D7Ex_2ndOrder_Op Isch_M_D7Ex_2ndOrderOp 0.4863 Yes 0.2151 No 
Isch_F_D7Ex_3rdOrder_Op Isch_M_D7Ex_3rdOrder_Op 0.0891 Yes 0.7188 No 
Isch_F_D7_2ndOrder_Op Isch_F_D7Ex_2ndOrder_Op 0.0622 Yes 0.0331 Yes 
Isch_F_D7_3rdOrder_Op Isch_F_D7Ex_3rdOrder_Op 0.1931 Yes 0.3644 No 
Isch_M_D7_1stOrder_Op Isch_M_D7Ex_1stOrder_Op 1.0000 Yes 0.0136 Yes 
Isch_M_D7_2ndOrder_Op Isch_M_D7Ex_2ndOrder_Op 0.7111 Yes 0.5888 No 
Isch_M_D7_1stOrder_Op Isch_M_D7Ex_1stOrder_Op 0.1836 Yes 0.5136 No 
Stem_F_D7_1stOrder_Op Stem_F_D7_1stOrder_Sham 0.8767 Yes 0.0051 Yes 
Stem_F_D7_2ndOrder_Op Stem_F_D7_2ndOrder_Sham 0.8097 Yes 0.1489 No 
Stem_F_D7_3rdOrder_Op Stem_F_D7_3rdOrder_Sham 0.8511 Yes 0.1685 No 
Stem_F_D7_1stOrder_Op Stem_F_D7_2ndOrder_Op 0.8914 Yes 0.0191 Yes 
Stem_F_D7_1stOrder_Op Stem_F_D7_3rdOrder_Op 0.5029 Yes 0.0013 Yes 
Stem_F_D7_2ndOrder_Op Stem_F_D7_3rdOrder_Op 0.5729 Yes 0.1469 No 
Stem_M_D7_1stOrder_Op Stem_M_D7_1stOrder_Sham 0.2114 Yes 0.1755 No 
Stem_M_D7_2ndOrder_Op Stem_M_D7_2ndOrder_Sham 0.1057 Yes 0.0562 No 
Stem_M_D7_1stOrder_Op Stem_M_D7_2ndOrder_Op 0.9698 Yes 0.7607 No 
Stem_F_D7_1stOrder_Op Stem_M_D7_1stOrder_Op 0.4236 Yes 0.9711 No 
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Group 1 Group 2 F-test 
Equal 
variances? 
ANOVA       
P-value 
Different 
means? 
Stem_F_D7_2ndOrder_Op Stem_M_D7_2ndOrderOp 0.3764 Yes 0.1919 No 
Stem_F_D21_1stOrder_Op Stem_F_D21_1stOrder_Sham 0.4425 Yes 0.1969 No 
Stem_F_D21_2ndOrdere_Op Stem_F_D21_2ndOrder_Sham 0.3303 Yes 0.5708 No 
Stem_F_D21_3rdOrder_Op Stem_F_D21_3rdOrder_Sham 0.3124 Yes 0.8463 No 
Stem_F_D21_1stOrder_Op Stem_F_D21_2ndOrder_Op 0.9382 Yes 0.0229 Yes 
Stem_F_D21_1stOrder_Op Stem_F_D21_3rdOrder_Op 0.2291 Yes 0.0801 No 
Stem_F_D21_2ndOrder_Op Stem_F_D21_3rdOrder_Op 0.2519 Yes 0.2541 No 
Stem_M_D21_1stOrder_Op Stem_M_D21_1stOrder_Sham 0.2804 Yes 0.0527 No 
Stem_M_D21_2ndOrder_Op Stem_M_D21_2ndOrder_Sham 0.3059 Yes 0.2635 No 
Stem_M_D21_3rdOrder_Op Stem_M_D21_3rdOrder_Sham 0.6496 Yes 0.8136 No 
Stem_M_D21_1stOrder_Op Stem_M_D21_2ndOrder_Op 0.4321 Yes 0.1603 No 
Stem_M_D21_1stOrder_Op Stem_M_D21_3rdOrder_Op 0.1509 Yes 0.0171 Yes 
Stem_M_D21_2ndOrder_Op Stem_M_D21_3rdOrder_Op 0.4079 Yes 0.0491 Yes 
Stem_F_D21_1stOrder_Op Stem_M_D21_1stOrder_Op 0.1554 Yes 0.6566 No 
Stem_F_D21_2ndOrder_Op Stem_M_D21_2ndOrder_Op 0.2655 Yes 0.6749 No 
Stem_F_D21_3rdOrder_Op Stem_M_D21_3rdOrder_Op 0.4546 Yes 0.9964 No 
Stem_F_D7_1stOrder_Op Stem_F_D21_1stOrder_Op 0.2310 Yes 0.6042 No 
Stem_F_D7_2ndOrder_Op Stem_F_D21_2ndOrder_Op 0.2693 Yes 0.9634 No 
Stem_F_D7_3rdOrder_Op Stem_F_D21_3rdOrder_Op 0.6013 Yes 0.7764 No 
Stem_M_D7_1stOrder_Op Stem_M_D21_1stOrder_Op 0.9112 Yes 0.9032 No 
Stem_M_D7_2ndOrder_Op Stem_M_D21_2ndOrder_Op 0.4399 Yes 0.4148 No 
Stem_M_D7_1stOrder_Op Stem_M_D21_1stOrder_Op 0.4885 Yes 0.6972 No 
Stem_F_D7Ex_1stOrder_Op Stem_F_D7Ex_1stOrder_Sham 0.8157 Yes 0.0001 Yes 
Stem_F_D7Ex_2ndOrder_Op Stem_F_D7Ex_2ndOrder_Sham 0.3654 Yes 0.0001 Yes 
Stem_F_D7Ex_1stOrder_Op Stem_F_D7Ex_2ndOrder_Op 0.3289 Yes 0.0262 Yes 
Stem_F_D7Ex_1stOrder_Op Stem_F_D7Ex_3rdOrder_Op 0.3402 Yes 0.0001 Yes 
Stem_F_D7Ex_2ndOrder_Op Stem_F_D7Ex_3rdOrder_Op 0.9810 Yes 0.0043 Yes 
Stem_M_D7Ex_2ndOrder_Op Stem_M_D7Ex_2ndOrder_Sham 0.8426 Yes 0.0001 Yes 
Stem_M_D7Ex_3rdOrder_Op Stem_M_D7Ex_3rdOrder_Sham 0.3791 Yes 0.0028 Yes 
Stem_M_D7Ex_1stOrder_Op Stem_M_D7Ex_2ndOrder_Op 0.2048 Yes 0.0003 Yes 
Stem_M_D7Ex_1stOrder_Op Stem_M_D7Ex_3rdOrder_Op 0.5704 Yes 0.0001 Yes 
Stem_M_D7Ex_2ndOrder_Op Stem_M_D7Ex_3rdOrder_Op 0.4609 Yes 0.0001 Yes 
Stem_F_D7Ex_1stOrder_Op Stem_M_D7Ex_1stOrder_Op 0.4213 Yes 0.6128 No 
Stem_F_D7Ex_2ndOrder_Op Stem_M_D7Ex_2ndOrderOp 0.1520 Yes 0.1304 No 
Stem_F_D7Ex_3rdOrder_Op Stem_M_D7Ex_3rdOrder_Op 0.4482 Yes 0.4886 No 
Stem_F_D7_1stOrder_Op Stem_F_D7Ex_1stOrder_Op 0.0681 Yes 0.3628 No 
Stem_F_D7_2ndOrder_Op Stem_F_D7Ex_2ndOrder_Op 0.4023 Yes 0.0501 No 
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Group 1 Group 2 F-test 
Equal 
variances? 
ANOVA       
P-value 
Different 
means? 
Stem_F_D7_3rdOrder_Op Stem_F_D7Ex_3rdOrder_Op 0.7266 Yes 0.4482 No 
Stem_M_D7_1stOrder_Op Stem_M_D7Ex_1stOrder_Op 0.0524 Yes 0.5916 No 
F_D7_1stOrder_Sham M_D7_1stOrder_Sham 0.6242 Yes 0.1977 No 
F_D7_1stOrder_Sham F_D21_1stOrder_Sham 0.2515 Yes 0.0829 No 
M_D7_1stOrder_Sham M_D21_1stOrder_Sham 0.6881 Yes 0.7224 No 
F_D7_1stOrder_Sham F_D7Ex_1stOrder_Sham 0.1225 Yes 0.3810 No 
ACC_F_D7_Sham ACC_F_D21_Sham 0.6284 Yes 0.7040 No 
ACC_F_D7_Sham ACC_F_D7Ex_Sham 0.7223 Yes 0.2219 No 
ACC_M_D7_sham ACC_M_D21_Sham 0.2156 Yes 0.1596 No 
ACC_M_d7_Sham ACC_M_D7Ex_sham 0.3269 Yes 0.6282 No 
ACC_F_D7_Sham ACC_M_d7_Sham 0.5683 Yes 0.0021 Yes 
ACC_F_D7Ex_Sham ACC_M_D7Ex_sham 0.9580 Yes 0.0653 No 
ACC_F_D21_Sham ACC_M_D21_Sham 0.8617 Yes 0.3200 No 
F_D7_2nOrder_Sham M_D7_2ndOrder_Sham 0.4067 Yes 0.6527 No 
F_D7_2ndOrder_Sham F_D21_2ndOrder_Sham 0.8215 Yes 0.358 No 
M_D7_2ndOrder_Sham M_D21_2ndOrder_Sham 0.9548 Yes 0.3421 No 
F_D7_2ndOrder_Sham F_D7Ex_2ndOrder_Sham 0.1266 Yes 0.4408 No 
F_D7_3rdOrder_Sham M_D7_3rdOrder_Sham 0.9530 Yes 0.3015 No 
F_D7_3rdOrder_Sham F_D21_3rdOrder_Sham 1.0000 Yes 1.0000 No 
M_D7_3rdOrder_Sham M_D21_3rdOrder_Sham 0.8364 Yes 0.8386 No 
M_D7_2ndOrder_Sham M_D7Ex_2ndOrder_Sham 0.2395 Yes 0.6822 No 
M_D7_3rdOrder_Sham M_D7Ex_3rdOrder_Sham 0.1117 Yes 0.1205 No 
 
 
 
 
F-test and Welch test (Dilated diameters): 
 
Group 1 Group 2 
F-test 
Value 
Equal 
Variances? 
Welch      
P-value 
Different 
Means? 
ACC_F_D7Ex_Op ACC_F_D7_Op 0.0343 No 0.1336 No 
PEC_M_D7_Reentry_Op PEC_M_D7_Stem_Op 0.0477 No 0.5492 No 
PEC_F_D7_Reentry_Op PEC_M_D7_Reentry_Op 0.0045 No 0.9955 No 
Isch_F_D7_1stOrder_Op Isch_F_D7Ex_1stOrder_Op 0.0121 No 0.8583 No 
Stem_M_D7_2ndOrder_Op Stem_M_D7Ex_2ndOrder_Op 0.0031 No 0.6708 No 
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Shapiro Wilk Normality Test: Percent Change: 
 
Sex Time Point Anatomical Location Limb P-value Normal? 
Female Day-7 ACC Operated 0.5210 Yes 
Female Day-7 ACC Sham 0.1019 Yes 
Male Day-7 ACC Operated 0.7404 Yes 
Male Day-7 ACC Sham 0.7651 Yes 
Female Day-21 ACC Operated 0.5110 Yes 
Female Day-21 ACC Sham 0.5188 Yes 
Male Day-21 ACC Operated 0.0019 No 
Male Day-21 ACC Sham 0.0759 Yes 
Female Day-7 Exercise ACC Operated 0.9445 Yes 
Female Day-7 Exercise ACC Sham 0.1733 Yes 
Male Day-7 Exercise ACC Operated 0.3229 Yes 
Male Day-7 Exercise ACC Sham 0.9862 Yes 
Female Day-7 PEC - Reentry Operated 0.7190 Yes 
Female Day-7 PEC - Midzone Operated 0.1037 Yes 
Female Day-7 PEC - Stem Operated 0.2907 Yes 
Female Day-7 Reentry Sham 0.9243 Yes 
Female Day-7 Midzone Sham 0.1466 Yes 
Female Day-7 Stem Sham 0.0561 Yes 
Male Day-7 PEC - Reentry Operated 0.4068 Yes 
Male Day-7 PEC - Midzone Operated 0.3201 Yes 
Male Day-7 PEC - Stem Operated 0.8715 Yes 
Male Day-7 Reentry Sham 0.9945 Yes 
Male Day-7 Midzone Sham 0.2980 Yes 
Male Day-7 Stem Sham 0.7803 Yes 
Female Day-21 PEC - Reentry Operated 0.0310 No 
Female Day-21 PEC - Midzone Operated 0.0349 No 
Female Day-21 PEC - Stem Operated 0.0570 Yes 
Female Day-21 Reentry Sham 0.1922 Yes 
Female Day-21 Midzone Sham 0.0723 Yes 
Female Day-21 Stem Sham 0.7704 Yes 
Male Day-21 PEC - Reentry Operated 0.5209 Yes 
Male Day-21 PEC - Midzone Operated 0.3160 Yes 
Male Day-21 PEC - Stem Operated 0.8202 Yes 
Male Day-21 Reentry Sham 0.1181 Yes 
Male Day-21 Midzone Sham 0.6888 Yes 
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Sex Time Point Anatomical Location Limb P-value Normal? 
Male Day-21 Stem Sham 0.5651 Yes 
Female Day-7 Ischemic Tree 1st Order Operated 0.4469 Yes 
Female Day-7 Ischemic Tree 2nd Order Operated 0.1700 Yes 
Female Day-7 Ischemic Tree 3rd Order Operated 0.7816 Yes 
Male Day-7 Ischemic Tree 1st Order Operated 0.1564 Yes 
Male Day-7 Ischemic Tree 2nd Order Operated 0.0908 Yes 
Male Day-7 Ischemic Tree 3rd Order Operated 0.7751 Yes 
Female Day-21 Ischemic Tree 1st Order Operated 0.7050 Yes 
Female Day-21 Ischemic Tree 2nd Order Operated 0.6638 Yes 
Female Day-21 Ischemic Tree 3rd Order Operated 0.3010 Yes 
Male Day-21 Ischemic Tree 1st Order Operated 0.2608 Yes 
Male Day-21 Ischemic Tree 2nd Order Operated 0.2168 Yes 
Male Day-21 Ischemic Tree 3rd Order Operated 0.0523 Yes 
Female Day-7 Exercise Ischemic Tree 1st Order Operated 0.8815 Yes 
Female Day-7 Exercise Ischemic Tree 2nd Order Operated 0.1187 Yes 
Female Day-7 Exercise Ischemic Tree 3rd Order Operated 0.4086 Yes 
Male Day-7 Exercise Ischemic Tree 1st Order Operated 0.1483 Yes 
Male Day-7 Exercise Ischemic Tree 2nd Order Operated 0.7819 Yes 
Male Day-7 Exercise Ischemic Tree 3rd Order Operated 0.0140 No 
Female Day-7 Stem 1st Order Operated 0.9861 Yes 
Female Day-7 Stem 2nd Order Operated 0.0539 Yes 
Female Day-7 Stem 3rd Order Operated 0.2082 Yes 
Male Day-7 Stem 1st Order Operated 0.6503 Yes 
Male Day-7 Stem 2nd Order Operated 0.7445 Yes 
Male Day-7 Stem 3rd Order Operated 0.2556 Yes 
Female Day-21 Stem 1st Order Operated 1.0000 Yes 
Female Day-21 Stem 2nd Order Operated 1.0000 Yes 
Female Day-21 Stem 3rd Order Operated 1.0000 Yes 
Male Day-21 Stem 1st Order Operated 0.7182 Yes 
Male Day-21 Stem 2nd Order Operated 0.9124 Yes 
Male Day-21 Stem 3rd Order Operated 0.6468 Yes 
Female Day-7 Exercise Stem 1st Order Operated 0.0851 Yes 
Female Day-7 Exercise Stem 2nd Order Operated 0.0631 Yes 
Female Day-7 Exercise Stem 3rd Order Operated 0.8075 Yes 
Male Day-7 Exercise Stem 1st Order Operated 0.6713 Yes 
Male Day-7 Exercise Stem 2nd Order Operated 0.9946 Yes 
Male Day-7 Exercise Stem 3rd Order Operated 0.2051 Yes 
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Sex Time Point Anatomical Location Limb P-value Normal? 
Female Day-7 Exercise Reentry Sham 0.8470 Yes 
Female Day-7 Exercise Midzone Sham 0.0538 Yes 
Female Day-7 Exercise Stem Sham 0.1346 Yes 
Male Day-7 Exercise Reentry Sham 0.8971 Yes 
Male Day-7 Exercise Midzone Sham 0.0399 No 
Male Day-7 Exercise Stem Sham 0.6196 Yes 
 
 
 
 
Levene’s test for equal variances and Wilcoxon test (Percent Change): 
 
Group 1 Group 2 
Levene    
P-value 
Equal 
variances? 
Wilcoxon    
P-value 
Different 
Means? 
ACC_M_D21_Op ACC_M_D21_Sham 0.5626 Yes 0.2594 No 
ACC_F_D21_Op ACC_M_D21_Op 0.6354 Yes 0.0235 Yes 
ACC_M_D7_Op ACC_M_D21_Op 0.1442 Yes 0.0005 Yes 
PEC_F_D21_Reentry_Op PEC_F_D21_Reentry_Sham 0.4801 Yes 0.0369 Yes 
PEC_F_D21_Midzone_Op PEC_F_D21_Midzone_Sham 0.8943 Yes 0.1709 No 
PEC_F_D21_Reentry_Op PEC_F_D21_Midzone_Op 0.2557 Yes 0.1360 No 
PEC_F_D21_Reentry_Op PEC_F_D21_Stem_Op 0.1093 Yes 0.0809 No 
PEC_F_D21_Midzone_Op PEC_F_D21_Stem_Op 0.5157 Yes 0.2330 No 
PEC_F_D21_Reentry_Op PEC_M_D21_Reentry_Op 0.3951 Yes 0.0933 No 
PEC_F_D21_Midzone_Op PEC_M_D21_Midzone_Op 0.2955 Yes 0.1243 No 
PEC_F_D7_Reentry_Op PEC_F_D21_Reentry_Op 0.1590 Yes 0.0518 Yes 
PEC_F_D7_Midzone_Op PEC_F_D21_Midzone_Op 0.6298 Yes 0.0373 Yes 
Isch_M_D7Ex_2ndOrder_Op Isch_M_D7Ex_2ndOrder_Sham 0.0607 Yes 0.0058 Yes 
Isch_M_D7Ex_3rdOrder_Op Isch_M_D7Ex_3rdOrder_Sham 0.5010 Yes 0.0081 Yes 
Isch_M_D7Ex_1stOrder_Op Isch_M_D7Ex_3rdOrder_Op 0.0278 No 0.0383 Yes 
Isch_M_D7Ex_2ndOrder_Op Isch_M_D7Ex_3rdOrder_Op 0.1215 Yes 0.0034 Yes 
Isch_F_D7Ex_3rdOrder_Op Isch_M_D7Ex_3rdOrder_Op 0.2689 Yes 0.7491 No 
Stem_M_D7Ex_2ndOrder_Op Stem_M_D7Ex_2ndOrder_Sham 0.3767 Yes 0.4208 No 
M_D7_2ndOrder_Sham M_D7Ex_2ndOrder_Sham 0.4170 Yes 0.5309 No 
 
 
 
 
 
 93 
F-test and ANOVA (Percent change): 
Group 1 Group 2 F-test 
Equal 
Variances? 
ANOVA     
P-value 
Different 
means? 
ACC_F_D7_Sham ACC_M_D7_Sham 0.3260 Yes 0.5956 No 
ACC_F_D21_Op ACC_F_D21_Sham 0.5131 Yes 0.2270 No 
ACC_F_D21_Sham ACC_M_D21_Sham 0.4624 Yes 0.1764 No 
ACC_F_D7Ex_Op ACC_F_D7Ex_Sham 0.1990 Yes 0.0001 Yes 
ACC_F_D7Ex_Op ACC_M_D7Ex_Op 0.3073 Yes 0.0421 Yes 
ACC_F_D7Ex_Sham ACC_M_D7Ex_Sham 0.1016 Yes 0.2927 No 
ACC_F_D7_Sham ACC_F_D21_Sham 0.1512 Yes 0.9713 No 
ACC_M_D7_Sham ACC_M_D21_Sham 0.8488 Yes 0.5257 No 
ACC_F_D7Ex_Sham ACC_F_d7_Sham 0.2858 Yes 0.6127 No 
ACC_M_D7Ex_Op ACC_M_D7_Op 0.0986 Yes 0.0008 Yes 
ACC_M_D7Ex_Sham ACC_M_D7_Sham 0.0911 Yes 0.2382 No 
PEC_F_D7_Reentry_Op PEC_F_D7_Reentry_Sham 0.8533 Yes 0.0232 Yes 
PEC_F_D7_Midzone_Op PEC_F_D7_Midzone_Sham 0.7398 Yes 0.0083 Yes 
PEC_F_D7_Stem_Op PEC_F_D7_Stem_Sham 0.8444 Yes 0.0101 Yes 
PEC_F_D7_Reentry_Op PEC_F_D7_Midzone_Op 0.5580 Yes 0.6160 No 
PEC_F_D7_Reentry_Op PEC_F_D7_Stem_Op 0.9974 Yes 0.6413 No 
PEC_F_D7_Midzone_Op PEC_F_D7_Stem_Op 0.5559 Yes 0.8968 No 
PEC_M_D7_Reentry_Op PEC_M_D7_Reentry_Sham 0.4580 Yes 0.1368 No 
PEC_M_D7_Midzone_Op PEC_M_D7_Midzone_Sham 0.3131 Yes 0.0013 Yes 
PEC_M_D7_Reentry_Op PEC_M_D7_Midzone_Op 0.7823 Yes 0.3605 No 
PEC_M_D7_Reentry_Op PEC_M_D7_Stem_Op 0.5049 Yes 0.5983 No 
PEC_M_D7_Midzone_Op PEC_M_D7_Stem_Op 0.3512 Yes 0.2171 No 
PEC_F_D7_Reentry_Op PEC_M_D7_Reentry_Op 0.5129 Yes 0.8223 No 
PEC_F_D7_Midzone_Op PEC_M_D7_Midzone_Op 0.8281 Yes 0.8331 No 
PEC_F_D7_Stem_Op PEC_M_D7_Stem_Op 0.2288 Yes 0.3444 No 
PEC_F_D21_Stem_Op PEC_F_D21_Stem_Sham 0.2508 Yes 0.0339 Yes 
PEC_M_D21_Reentry_Op PEC_M_D21_Reentry_Sham 0.4170 Yes 0.0374 Yes 
PEC_M_D21_Stem_Op PEC_M_D21_Stem_Sham 0.1204 Yes 0.0119 Yes 
PEC_M_D21_Reentry_Op PEC_M_D21_Stem_Op 0.1107 Yes 0.0149 Yes 
PEC_M_D21_Midzone_Op PEC_M_D21_Stem_Op 0.4214 Yes 0.9719 No 
PEC_F_D21_Stem_Op PEC_M_D21_Stem_Op 0.7040 Yes 0.4934 No 
PEC_F_D7_Stem_Op PEC_F_D21_Stem_Op 0.7698 Yes 0.0008 Yes 
PEC_M_D7_Reentry_Op PEC_M_D21_Reentry_Op 0.1488 Yes 0.0097 Yes 
PEC_M_D7_Midzone_Op PEC_M_D21_Midzone_Op 0.2190 Yes 0.0012 Yes 
PEC_M_D7_Stem_Op PEC_M_D21_Stem_Op 0.6052 Yes 0.0131 Yes 
Isch_F_D7_1stOrder_Op Isch_F_D7_1stOrder_Sham 0.5161 Yes 0.0057 Yes 
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Group 1 Group 2 F-test 
Equal 
Variances? 
ANOVA     
P-value 
Different 
means? 
Isch_F_D7_2ndOrder_Op Isch_F_D7_2ndOrder_Sham 0.1040 Yes 0.0001 Yes 
Isch_F_D7_3rdOrder_Op Isch_F_D7_3rdOrder_Sham 0.6732 Yes 0.0025 Yes 
Isch_F_D7_1stOrder_Op Isch_F_D7_3rdOrder_Op 0.4087 Yes 0.8311 No 
Isch_F_D7_2ndOrder_Op Isch_F_D7_3rdOrder_Op 0.4560 Yes 0.1565 No 
Isch_M_D7_1stOrder_Op Isch_M_D7_1stOrder_Sham 0.1427 Yes 0.0008 Yes 
Isch_M_D7_3rdOrder_Op Isch_M_D7_3rdOrder_Sham 0.5282 Yes 0.0001 Yes 
Isch_M_D7_1stOrder_Op Isch_M_D7_2ndOrder_Op 0.3224 Yes 0.9549 No 
Isch_M_D7_1stOrder_Op Isch_M_D7_3rdOrder_Op 0.2010 Yes 0.5508 No 
Isch_F_D7_1stOrder_Op Isch_M_D7_1stOrder_Op 0.0647 Yes 0.3466 No 
Isch_F_D7_2ndOrder_Op Isch_M_D7_2ndOrderOp 0.1052 Yes 0.9722 No 
Isch_F_D7_3rdOrder_Op Isch_M_D7_3rdOrder_Op 0.9233 Yes 0.5765 No 
Isch_F_D21_1stOrder_Op Isch_F_D21_1stOrder_Sham 0.6015 Yes 0.8573 No 
Isch_F_D21_2ndOrder_Op Isch_F_D21_2ndOrder_Sham 0.3773 Yes 0.7637 No 
Isch_F_D21_3rdOrder_Op Isch_F_D21_3rdOrder_Sham 0.0935 Yes 0.3349 No 
Isch_F_D21_1stOrder_Op Isch_F_D21_2ndOrder_Op 0.6426 Yes 0.9381 No 
Isch_F_D21_1stOrder_Op Isch_F_D21_3rdOrder_Op 0.7482 Yes 0.6086 No 
Isch_F_D21_2ndOrder_Op Isch_F_D21_3rdOrder_Op 0.7482 Yes 0.6086 No 
Isch_M_D21_1stOrder_Op Isch_M_D21_1stOrder_Sham 0.4603 Yes 0.6047 No 
Isch_M_D21_1stOrder_Op Isch_M_D21_3rdOrder_Op 0.5491 Yes 0.5633 No 
Isch_M_D21_2ndOrder_Op Isch_M_D21_3rdOrder_Op 0.3201 Yes 0.1600 No 
Isch_F_D21_1stOrder_Op Isch_M_D21_1stOrder_Op 0.6697 Yes 0.4003 No 
Isch_F_D21_2ndOrder_Op Isch_M_D21_2ndOrder_Op 0.8962 Yes 0.1868 No 
Isch_F_D21_3rdOrder_Op Isch_M_D21_3rdOrder_Op 0.2980 Yes 0.5454 No 
Isch_F_D7_1stOrder_Op Isch_F_D21_1stOrder_Op 0.6883 Yes 0.5786 No 
Isch_F_D7_2ndOrder_Op Isch_F_D21_2ndOrder_Op 0.8089 Yes 0.0058 Yes 
Isch_F_D7_3rdOrder_Op Isch_F_D21_3rdOrder_Op 0.2282 Yes 0.0001 Yes 
Isch_M_D7_1stOrder_Op Isch_M_D21_1stOrder_Op 0.3736 Yes 0.0108 Yes 
Isch_M_D7_2ndOrder_Op Isch_M_D21_2ndOrder_Op 0.0626 Yes 0.0011 Yes 
Isch_F_D7Ex_1stOrder_Op Isch_F_D7Ex_1stOrder_Sham 0.2243 Yes 0.0036 Yes 
Isch_F_D7Ex_2ndOrder_Op Isch_F_D7Ex_2ndOrder_Sham 0.1202 Yes 0.0001 Yes 
Isch_F_D7Ex_2ndOrder_Op Isch_F_D7Ex_3rdOrder_Op 0.9024 Yes 0.7909 No 
Isch_M_D7Ex_1stOrder_Op Isch_M_D7Ex_2ndOrder_Op 0.5347 Yes 0.0891 No 
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Group 1 Group 2 F-test 
Equal 
Variances? 
ANOVA     
P-value 
Different 
means? 
Isch_F_D7Ex_1stOrder_Op Isch_M_D7Ex_1stOrder_Op 0.1732 Yes 0.0233 Yes 
Isch_F_D7Ex_2ndOrder_Op Isch_M_D7Ex_2ndOrderOp 0.5181 Yes 0.1072 No 
Isch_F_D7_2ndOrder_Op Isch_F_D7Ex_2ndOrder_Op 0.6366 Yes 0.1723 No 
Isch_F_D7_3rdOrder_Op Isch_F_D7Ex_3rdOrder_Op 0.2646 Yes 0.6066 No 
Isch_M_D7_1stOrder_Op Isch_M_D7Ex_1stOrder_Op 0.6767 Yes 0.0870 No 
Isch_M_D7_2ndOrder_Op Isch_M_D7Ex_2ndOrder_Op 0.2681 Yes 0.8050 No 
Isch_M_D7_1stOrder_Op Isch_M_D7Ex_1stOrder_Op 0.3032 Yes 0.2726 No 
Stem_F_D7_1stOrder_Op Stem_F_D7_1stOrder_Sham 0.1856 Yes 0.7362 No 
Stem_F_D7_2ndOrder_Op Stem_F_D7_2ndOrder_Sham 0.0719 Yes 0.4432 No 
Stem_F_D7_3rdOrder_Op Stem_F_D7_3rdOrder_Sham 0.0852 Yes 0.3265 No 
Stem_F_D7_1stOrder_Op Stem_F_D7_2ndOrder_Op 0.5121 Yes 0.4614 No 
Stem_F_D7_1stOrder_Op Stem_F_D7_3rdOrder_Op 0.4479 Yes 0.3528 No 
Stem_F_D7_2ndOrder_Op Stem_F_D7_3rdOrder_Op 0.8908 Yes 0.8204 No 
Stem_M_D7_1stOrder_Op Stem_M_D7_1stOrder_Sham 0.1679 Yes 0.7614 No 
Stem_M_D7_2ndOrder_Op Stem_M_D7_2ndOrder_Sham 0.7332 Yes 0.0019 Yes 
Stem_M_D7_3rdOrder_Op Stem_M_D7_3rdOrder_Sham 0.0617 Yes 0.0078 Yes 
Stem_M_D7_1stOrder_Op Stem_M_D7_2ndOrder_Op 0.2562 Yes 0.3045 No 
Stem_M_D7_1stOrder_Op Stem_M_D7_3rdOrder_Op 0.8118 Yes 0.2634 No 
Stem_M_D7_2ndOrder_Op Stem_M_D7_3rdOrder_Op 0.3539 Yes 0.6641 No 
Stem_F_D7_1stOrder_Op Stem_M_D7_1stOrder_Op 0.7755 Yes 0.5208 No 
Stem_F_D7_2ndOrder_Op Stem_M_D7_2ndOrderOp 0.1714 Yes 0.0632 No 
Stem_F_D7_3rdOrder_Op Stem_M_D7_3rdOrder_Op 0.5994 Yes 0.0459 Yes 
Stem_F_D21_1stOrder_Op Stem_F_D21_1stOrder_Sham 0.5987 Yes 0.2586 No 
Stem_F_D21_2ndOrdere_Op Stem_F_D21_2ndOrder_Sham 0.8588 Yes 0.3354 No 
Stem_F_D21_3rdOrder_Op Stem_F_D21_3rdOrder_Sham 0.0518 Yes 0.9805 No 
Stem_F_D21_1stOrder_Op Stem_F_D21_2ndOrder_Op 0.4780 Yes 0.1132 No 
Stem_F_D21_1stOrder_Op Stem_F_D21_3rdOrder_Op 0.2617 Yes 0.6760 No 
Stem_F_D21_2ndOrder_Op Stem_F_D21_3rdOrder_Op 0.6195 Yes 0.4519 No 
Stem_M_D21_3rdOrder_Op Stem_M_D21_3rdOrder_Sham 0.6062 Yes 0.4109 No 
Stem_M_D21_1stOrder_Op Stem_M_D21_2ndOrder_Op 0.9048 Yes 0.2732 No 
Stem_F_D21_1stOrder_Op Stem_M_D21_1stOrder_Op 0.3229 Yes 0.9910 No 
Stem_F_D21_2ndOrder_Op Stem_M_D21_2ndOrder_Op 0.7255 Yes 0.7197 No 
Stem_F_D7_1stOrder_Op Stem_F_D21_1stOrder_Op 0.3100 Yes 0.5861 No 
Stem_F_D7_2ndOrder_Op Stem_F_D21_2ndOrder_Op 0.5700 Yes 0.3648 No 
 
 
 
 96 
Group 1 Group 2 F-test 
Equal 
Variances? 
ANOVA     
P-value 
Different 
means? 
Stem_F_D7_3rdOrder_Op Stem_F_D21_3rdOrder_Op 0.9568 Yes 0.9449 No 
Stem_M_D7_1stOrder_Op Stem_M_D21_1stOrder_Op 0.7679 Yes 0.2818 No 
Stem_M_D7_2ndOrder_Op Stem_M_D21_2ndOrder_Op 0.2868 Yes 0.0080 Yes 
Stem_M_D7_3rdOrder_Op Stem_M_D21_3rdOrder_Op 0.0584 Yes 0.0324 Yes 
Stem_F_D7Ex_1stOrder_Op Stem_F_D7Ex_1stOrder_Sham 0.6405 Yes 0.0043 Yes 
Stem_F_D7Ex_2ndOrder_Op Stem_F_D7Ex_2ndOrder_Sham 0.9224 Yes 0.0297 Yes 
Stem_F_D7Ex_3rdOrder_Op Stem_F_D7Ex_3rdOrder_Sham 0.6733 Yes 0.0276 Yes 
Stem_F_D7Ex_1stOrder_Op Stem_F_D7Ex_2ndOrder_Op 0.7187 Yes 0.1924 No 
Stem_F_D7Ex_1stOrder_Op Stem_F_D7Ex_3rdOrder_Op 0.3175 Yes 0.0268 Yes 
Stem_F_D7Ex_2ndOrder_Op Stem_F_D7Ex_3rdOrder_Op 0.5130 Yes 0.1725 No 
Stem_M_D7Ex_1stOrder_Op Stem_M_D7Ex_1stOrder_Sham 0.9931 Yes 0.4486 No 
Stem_M_D7Ex_3rdOrder_Op Stem_M_D7Ex_3rdOrder_Sham 0.1044 Yes 0.9769 No 
Stem_M_D7Ex_1stOrder_Op Stem_M_D7Ex_2ndOrder_Op 0.4251 Yes 0.2202 No 
Stem_M_D7Ex_1stOrder_Op Stem_M_D7Ex_3rdOrder_Op 0.5847 Yes 0.9665 No 
Stem_M_D7Ex_2ndOrder_Op Stem_M_D7Ex_3rdOrder_Op 0.7866 Yes 0.2524 No 
Stem_F_D7Ex_1stOrder_Op Stem_M_D7Ex_1stOrder_Op 0.3464 Yes 0.9078 No 
Stem_F_D7Ex_2ndOrder_Op Stem_M_D7Ex_2ndOrderOp 0.2236 Yes 0.8197 No 
Stem_F_D7Ex_3rdOrder_Op Stem_M_D7Ex_3rdOrder_Op 0.7388 Yes 0.0501 No 
Stem_F_D7_1stOrder_Op Stem_F_D7Ex_1stOrder_Op 0.0828 Yes 0.9884 No 
Stem_F_D7_2ndOrder_Op Stem_F_D7Ex_2ndOrder_Op 0.0533 Yes 0.8271 No 
Stem_F_D7_3rdOrder_Op Stem_F_D7Ex_3rdOrder_Op 0.1511 Yes 0.7719 No 
Stem_M_D7_1stOrder_Op Stem_M_D7Ex_1stOrder_Op 0.2589 Yes 0.4244 No 
Stem_M_D7_2ndOrder_Op Stem_M_D7Ex_2ndOrder_Op 0.3812 Yes 0.0107 Yes 
Stem_M_D7_1stOrder_Op Stem_M_D7Ex_1stOrder_Op 0.6851 Yes 0.0233 Yes 
F_D7_1stOrder_Sham M_D7_1stOrder_Sham 0.8247 Yes 0.6041 No 
F_D7_1stOrder_Sham F_D21_1stOrder_Sham 0.8688 Yes 0.0324 Yes 
M_D7_1stOrder_Sham M_D21_1stOrder_Sham 0.1332 Yes 0.7570 No 
F_D7_1stOrder_Sham F_D7Ex_1stOrder_Sham 0.2387 Yes 0.0293 Yes 
ACC_F_D7_Sham ACC_F_D21_Sham 0.1512 Yes 0.9713 No 
ACC_F_D7_Sham ACC_F_D7Ex_Sham 0.2858 Yes 0.6127 No 
ACC_M_D7_sham ACC_M_D21_Sham 0.8488 Yes 0.5257 No 
ACC_M_d7_Sham ACC_M_D7Ex_sham 0.0911 Yes 0.2382 No 
ACC_F_D7_Sham ACC_M_d7_Sham 0.3260 Yes 0.5956 No 
ACC_F_D7Ex_Sham ACC_M_D7Ex_sham 0.1016 Yes 0.2927 No 
ACC_F_D21_Sham ACC_M_D21_Sham 0.4624 Yes 0.1764 No 
F_D7_2nOrder_Sham M_D7_2ndOrder_Sham 0.3249 Yes 0.7211 No 
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Group 1 Group 2 F-test 
Equal 
Variances? 
ANOVA     
P-value 
Different 
means? 
F_D7_2ndOrder_Sham F_D21_2ndOrder_Sham 0.4293 Yes 0.0960 No 
M_D7_2ndOrder_Sham M_D21_2ndOrder_Sham 1.0000 Yes 1.0000 No 
F_D7_2ndOrder_Sham F_D7Ex_2ndOrder_Sham 0.5300 Yes 0.1991 No 
F_D7_3rdOrder_Sham M_D7_3rdOrder_Sham 0.2463 Yes 0.7437 No 
F_D7_3rdOrder_Sham F_D21_3rdOrder_Sham 0.2370 Yes 0.0198 Yes 
M_D7_3rdOrder_Sham M_D21_3rdOrder_Sham 0.8129 Yes 0.5585 No 
M_D7_3rdOrder_Sham M_D7Ex_3rdOrder_Sham 0.8281 Yes 0.5563 No 
 
 
 
F-test and Welch (Percent Change): 
Group 1 Group 2 F-test  
Equal 
Variances? 
Welch     
P-value 
Different 
means? 
ACC_F_D7_Op ACC_F_D7_Sham 0.0001 No 0.0001 Yes 
ACC_M_D7_Op ACC_M_D7_Sham 0.0302 No 0.0001 Yes 
ACC_F_D7_Op ACC_M_D7_Op 0.0005 No 0.0732 No 
ACC_M_D7Ex_Op ACC_M_D7Ex_Sham 0.0151 No 0.0010 Yes 
ACC_F_D7_Op ACC_F_D21_Op 0.0001 No 0.0001 Yes 
ACC_F_D7Ex_Op ACC_F_D7_Op 0.0001 No 0.0013 Yes 
PEC_M_D7_Stem_Op PEC_M_D7_Stem_Sham 0.0302 No 0.1931 No 
PEC_M_D21_Midzone_Op PEC_M_D21_Midzone_Sham 0.0007 No 0.0150 Yes 
PEC_M_D21_Reentry_Op PEC_M_D21_Midzone_Op 0.0156 No 0.0350 Yes 
Isch_F_D7_1stOrder_Op Isch_F_D7_2ndOrder_Op 0.0723 No 0.3926 No 
Isch_M_D7_2ndOrder_Op Isch_M_D7_2ndOrder_Sham 0.0514 No 0.0001 Yes 
Isch_M_D7_2ndOrder_Op Isch_M_D7_3rdOrder_Op 0.0420 No 0.5763 No 
Isch_M_D21_2ndOrder_Op Isch_M_D21_2ndOrder_Sham 0.0123 No 0.1938 No 
Isch_M_D21_3rdOrder_Op Isch_M_D21_3rdOrder_Sham 0.0024 No 0.0974 No 
Isch_M_D21_1stOrder_Op Isch_M_D21_2ndOrder_Op 0.0304 No 0.5498 No 
Isch_M_D7_3rdOrder_Op Isch_M_D21_3rdOrder_Op 0.0075 No 0.0004 Yes 
Stem_M_D21_1stOrder_Op Stem_M_D21_1stOrder_Sham 0.0057 No 0.2421 No 
Stem_M_D21_2ndOrder_Op Stem_M_D21_2ndOrder_Sham 0.0020 No 0.0365 Yes 
Stem_M_D21_1stOrder_Op Stem_M_D21_3rdOrder_Op 0.0444 No 0.5098 No 
Stem_M_D21_2ndOrder_Op Stem_M_D21_3rdOrder_Op 0.0358 No 0.0343 Yes 
Stem_F_D21_3rdOrder_Op Stem_M_D21_3rdOrder_Op 0.0489 No 0.3870 No 
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Paired t-test: Resting vs. Dilated Diameters: 
Sex Time Point Anatomical Location Limb P-value 
Different 
diameters? 
Female Day-7 ACC Operated 1.078E-07 Yes 
Male Day-7 ACC Operated 3.822E-03 Yes 
Female Day-21 ACC Operated 2.130E-06 Yes 
Male Day-21 ACC Operated 4.728E-10 Yes 
Female Day-7 Exercise ACC Operated 3.167E-04 Yes 
Male Day-7 Exercise ACC Operated 3.870E-05 Yes 
Female Day-7 PEC - Reentry Operated 1.519E-02 Yes 
Female Day-7 PEC - Midzone Operated 3.173E-02 Yes 
Female Day-7 PEC - Stem Operated 1.146E-02 Yes 
Female Day-21 PEC - Reentry Operated 2.629E-02 Yes 
Female Day-21 PEC - Midzone Operated 1.590E-02 Yes 
Female Day-21 PEC - Stem Operated 3.540E-02 Yes 
Male Day-7 PEC - Reentry Operated 2.167E-03 Yes 
Male Day-7 PEC - Midzone Operated 5.815E-03 Yes 
Male Day-7 PEC - Stem Operated 6.895E-03 Yes 
Male Day-21 PEC - Reentry Operated 8.218E-05 Yes 
Male Day-21 PEC - Midzone Operated 1.452E-05 Yes 
Male Day-21 PEC - Stem Operated 9.993E-04 Yes 
Female Day-7 Ischemic Tree 1st Order Operated 3.096E-02 Yes 
Female Day-7 Ischemic Tree 2nd Order Operated 2.675E-02 Yes 
Female Day-7 Ischemic Order 3rd Order Operated 5.252E-02 No 
Female Day-21 Ischemic Tree 1st Order Operated 3.640E-03 Yes 
Female Day-21 Ischemic Tree 2nd Order Operated 4.230E-03 Yes 
Female Day-21 Ischemic Order 3rd Order Operated 1.640E-02 Yes 
Female Day-7 Exercise Ischemic Tree 1st Order Operated 5.578E-05 Yes 
Female Day-7 Exercise Ischemic Tree 2nd Order Operated 2.740E-04 Yes 
Female Day-7 Exercise Ischemic Order 3rd Order Operated 3.568E-03 Yes 
Male Day-7 Ischemic Tree 1st Order Operated 1.321E-02 Yes 
Male Day-7 Ischemic Tree 2nd Order Operated 1.240E-02 Yes 
Male Day-7 Ischemic Order 3rd Order Operated 8.638E-02 No 
Male Day-21 Ischemic Tree 1st Order Operated 1.200E-04 Yes 
Male Day-21 Ischemic Tree 2nd Order Operated 4.292E-07 Yes 
Male Day-21 Ischemic Order 3rd Order Operated 6.890E-05 Yes 
Male Day-7 Exercise Ischemic Tree 1st Order Operated 1.416E-05 Yes 
Male Day-7 Exercise Ischemic Tree 2nd Order Operated 7.125E-04 Yes 
Male Day-7 Exercise Ischemic Order 3rd Order Operated 7.334E-04 Yes 
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Female Day-7 Stem 1st Order Operated 4.419E-04 Yes 
Female Day-7 Stem 2nd Order Operated 2.611E-04 Yes 
Female Day-7 Stem 3rd Order Operated 9.409E-04 Yes 
Female Day-21 Stem 1st Order Operated 1.500E-02 Yes 
Female Day-21 Stem 2nd Order Operated 6.240E-04 Yes 
Female Day-21 Stem 3rd Order Operated 1.010E-01 No 
Female Day-7 Exercise Stem 1st Order Operated 2.095E-05 Yes 
Female Day-7 Exercise Stem 2nd Order Operated 7.583E-05 Yes 
Female Day-7 Exercise Stem 3rd Order Operated 3.390E-04 Yes 
Male Day-7 Stem 1st Order Operated 1.135E-02 Yes 
Male Day-7 Stem 2nd Order Operated 2.372E-02 Yes 
Male Day-7 Stem 3rd Order Operated 9.478E-02 No 
Male Day-21 Stem 1st Order Operated 4.090E-03 Yes 
Male Day-21 Stem 2nd Order Operated 5.600E-04 Yes 
Male Day-21 Stem 3rd Order Operated 1.750E-03 Yes 
Male Day-7 Exercise Stem 1st Order Operated 2.850E-07 Yes 
Male Day-7 Exercise Stem 2nd Order Operated 2.073E-07 Yes 
Male Day-7 Exercise Stem 3rd Order Operated 4.410E-06 Yes 
Female Day-7 ACC Sham 4.578E-06 Yes 
Male Day-7 ACC Sham 3.534E-07 Yes 
Female Day-21 ACC Sham 1.770E-05 Yes 
Male Day-21 ACC Sham 6.418E-06 Yes 
Female Day-7 Exercise ACC Sham 8.198E-05 Yes 
Male Day-7 Exercise ACC Sham 7.536E-05 Yes 
Female Day-7 1st Order Sham 8.650E-05 Yes 
Female Day-7 2nd Order Sham 4.426E-05 Yes 
Female Day-7 3rd Order Sham 1.022E-03 Yes 
Male Day-7 1st Order Sham 3.511E-06 Yes 
Male Day-7 2nd Order Sham 2.060E-04 Yes 
Male Day-7 3rd Order Sham 2.129E-04 Yes 
Female Day-21 1st Order Sham 7.669E-05 Yes 
Female Day-21 2nd Order Sham 1.490E-04 Yes 
Female Day-21 3rd Order Sham 2.323E-04 Yes 
Male Day-21 1st Order Sham 5.768E-06 Yes 
Male Day-21 2nd Order Sham 7.339E-06 Yes 
Male Day-21 3rd Order Sham 5.365E-04 Yes 
Female Day-7 Exercise 1st Order Sham 2.430E-04 Yes 
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Female Day-7 Exercise 2nd Order Sham 2.315E-05 Yes 
Female Day-7 Exercise 3rd Order Sham 1.692E-03 Yes 
Male Day-7 Exercise 1st Order Sham 2.934E-04 Yes 
Male Day-7 Exercise 2nd Order Sham 1.379E-04 Yes 
Male Day-7 Exercise 3rd Order Sham 7.627E-05 Yes 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
